TIMKEN CO
10-Qs and 10-Ks
PROXIES
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
10-Q
|
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||
For the quarterly period ended
March 31, 2023
OR
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||
For the transition period from
to
Commission file number:
1-1169
THE
TIMKEN CO
MPANY
(Exact name of registrant as specified in its charter)
|
|
|
||||||||||
|
(State or other jurisdiction of
incorporation or organization) |
(I.R.S. Employer
Identification No.) |
||||||||||
|
|
|||||||||||
|
|
|
|
|||||||||
| (Address of principal executive offices) | (Zip Code) | ||||||||||
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol | Name of each exchange on which registered | ||||||||||||||||||
|
|
|
|
||||||||||||||||||
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes
☒
No
☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Yes
☒
No
☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
|
|
☒ | Accelerated filer |
☐
|
||||||||||||||
| Non-accelerated filer |
☐
|
Smaller reporting company |
|
||||||||||||||
| Emerging growth company |
|
||||||||||||||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes
☐
No
☒
Indicate the number of shares outstanding of each of the issuer's classes of common shares, as of the latest practicable date.
| Class |
Outstanding at March 31, 2023
|
|||||||||||||
| Common Shares, without par value |
|
|||||||||||||
THE TIMKEN COMPANY
INDEX TO FORM 10-Q REPORT
| PAGE | |||||||||||
| I. | |||||||||||
| Item 1. | |||||||||||
| Item 2. | |||||||||||
| Item 3. | |||||||||||
| Item 4. | |||||||||||
| II. | |||||||||||
| Item 1. | |||||||||||
| Item1A. | |||||||||||
| Item 2. | |||||||||||
| Item 6. | |||||||||||
PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
THE TIMKEN COMPANY AND SUBSIDIARIES
Consolidated Statements of Income
(Unaudited)
|
Three Months Ended
March 31, |
|||||||||||
| 2023 | 2022 | ||||||||||
| (Dollars in millions, except per share data) | |||||||||||
| Net sales | $ |
|
$ |
|
|||||||
| Cost of products sold |
|
|
|||||||||
| Selling, general and administrative expenses |
|
|
|||||||||
| Amortization of intangible assets |
|
|
|||||||||
| Impairment and restructuring charges |
|
|
|||||||||
| Operating Income |
|
|
|||||||||
| Interest expense |
(
|
(
|
|||||||||
| Interest income |
|
|
|||||||||
| Non-service pension and other postretirement income |
|
|
|||||||||
| Other income, net |
|
|
|||||||||
| Income Before Income Taxes |
|
|
|||||||||
| Provision for income taxes |
|
|
|||||||||
| Net Income |
|
|
|||||||||
| Less: Net income attributable to noncontrolling interest |
|
|
|||||||||
| Net Income Attributable to The Timken Company | $ |
|
$ |
|
|||||||
|
Net Income per Common Share Attributable to The Timken
Company Common Shareholders |
|||||||||||
| Basic earnings per share | $ |
|
$ |
|
|||||||
| Diluted earnings per share | $ |
|
$ |
|
|||||||
See accompanying Notes to the Consolidated Financial Statements.
Consolidated Statements of Comprehensive Income
(Unaudited)
|
Three Months Ended
March 31, |
|||||||||||
| 2023 | 2022 | ||||||||||
| (Dollars in millions) | |||||||||||
| Net Income | $ |
|
$ |
|
|||||||
| Other comprehensive income (loss), net of tax: | |||||||||||
| Foreign currency translation adjustments |
|
(
|
|||||||||
| Pension and postretirement liability adjustments |
(
|
(
|
|||||||||
| Change in fair value of derivative financial instruments |
(
|
|
|||||||||
| Other comprehensive income (loss), net of tax |
|
(
|
|||||||||
| Comprehensive income, net of tax |
|
|
|||||||||
| Less: comprehensive income attributable to noncontrolling interest |
|
|
|||||||||
| Comprehensive income attributable to The Timken Company | $ |
|
$ |
|
|||||||
See accompanying Notes to the Consolidated Financial Statements.
1
Consolidated Balance Sheets
| (Unaudited) | |||||||||||
| (Dollars in millions) |
March 31,
2023 |
December 31,
2022 |
|||||||||
| ASSETS | |||||||||||
| Current Assets | |||||||||||
| Cash and cash equivalents | $ |
|
$ |
|
|||||||
| Restricted cash |
|
|
|||||||||
|
Accounts receivable, less allowances (2023 – $
|
|
|
|||||||||
| Unbilled receivables |
|
|
|||||||||
| Inventories, net |
|
|
|||||||||
| Deferred charges and prepaid expenses |
|
|
|||||||||
| Other current assets |
|
|
|||||||||
| Total Current Assets |
|
|
|||||||||
| Property, Plant and Equipment, net |
|
|
|||||||||
| Other Assets | |||||||||||
| Goodwill |
|
|
|||||||||
| Other intangible assets |
|
|
|||||||||
| Operating lease assets |
|
|
|||||||||
| Deferred income taxes |
|
|
|||||||||
| Other non-current assets |
|
|
|||||||||
| Total Other Assets |
|
|
|||||||||
| Total Assets | $ |
|
$ |
|
|||||||
| LIABILITIES AND EQUITY | |||||||||||
| Current Liabilities | |||||||||||
| Accounts payable, trade |
|
|
|||||||||
| Short-term debt, including current portion of long-term debt |
|
|
|||||||||
| Salaries, wages and benefits |
|
|
|||||||||
| Income taxes payable |
|
|
|||||||||
| Other current liabilities |
|
|
|||||||||
| Total Current Liabilities |
|
|
|||||||||
| Non-Current Liabilities | |||||||||||
| Long-term debt |
|
|
|||||||||
| Accrued pension benefits |
|
|
|||||||||
| Accrued postretirement benefits |
|
|
|||||||||
| Long-term operating lease liabilities |
|
|
|||||||||
| Deferred income taxes |
|
|
|||||||||
| Other non-current liabilities |
|
|
|||||||||
| Total Non-Current Liabilities |
|
|
|||||||||
| Shareholders’ Equity | |||||||||||
| Class I and II Serial Preferred Stock, without par value: | |||||||||||
|
Authorized –
|
|
|
|||||||||
| Common shares, without par value: | |||||||||||
|
Authorized –
|
|||||||||||
|
Issued (including shares in treasury) (2023 –
2022 –
|
|||||||||||
| Stated capital |
|
|
|||||||||
| Other paid-in capital |
|
|
|||||||||
| Retained earnings |
|
|
|||||||||
| Accumulated other comprehensive loss |
(
|
(
|
|||||||||
|
Treasury shares at cost (2023 –
|
(
|
(
|
|||||||||
| Total Shareholders’ Equity |
|
|
|||||||||
| Noncontrolling Interest |
|
|
|||||||||
| Total Equity |
|
|
|||||||||
| Total Liabilities and Equity | $ |
|
$ |
|
|||||||
See accompanying Notes to the Consolidated Financial Statements.
2
Consolidated Statements of Cash Flows
(Unaudited)
|
Three Months Ended
March 31, |
|||||||||||
| 2023 | 2022 | ||||||||||
| (Dollars in millions) | |||||||||||
| CASH PROVIDED (USED) | |||||||||||
| Operating Activities | |||||||||||
| Net income | $ |
|
$ |
|
|||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Depreciation and amortization |
|
|
|||||||||
| Impairment charges |
|
|
|||||||||
| Loss on sale of assets |
|
|
|||||||||
| Gain on divestitures |
(
|
|
|||||||||
| Deferred income tax provision |
|
|
|||||||||
| Stock-based compensation expense |
|
|
|||||||||
| Pension and other postretirement expense |
|
|
|||||||||
| Pension and other postretirement benefit contributions and payments |
(
|
(
|
|||||||||
| Changes in operating assets and liabilities: | |||||||||||
| Accounts receivable |
(
|
(
|
|||||||||
| Unbilled receivables |
(
|
|
|||||||||
| Inventories |
|
(
|
|||||||||
| Accounts payable, trade |
(
|
|
|||||||||
| Other accrued expenses |
(
|
(
|
|||||||||
| Income taxes |
(
|
|
|||||||||
| Other, net |
(
|
|
|||||||||
| Net Cash Provided by (Used in) Operating Activities |
|
(
|
|||||||||
| Investing Activities | |||||||||||
| Capital expenditures |
(
|
(
|
|||||||||
| Acquisitions, net of cash acquired |
(
|
|
|||||||||
| Proceeds from divestitures, net of cash divested |
|
|
|||||||||
| Investments in short-term marketable securities, net |
|
(
|
|||||||||
| Other, net |
(
|
|
|||||||||
| Net Cash Used in Investing Activities |
(
|
(
|
|||||||||
| Financing Activities | |||||||||||
| Cash dividends paid to shareholders |
(
|
(
|
|||||||||
| Purchase of treasury shares |
(
|
(
|
|||||||||
| Proceeds from exercise of stock options |
|
|
|||||||||
| Payments related to tax withholding for stock-based compensation |
(
|
(
|
|||||||||
| Borrowings on accounts receivable facility |
|
|
|||||||||
| Payments on accounts receivable facility |
(
|
(
|
|||||||||
| Proceeds from long-term debt |
|
|
|||||||||
| Payments on long-term debt |
(
|
(
|
|||||||||
| Deferred financing costs |
|
(
|
|||||||||
| Short-term debt activity, net |
(
|
(
|
|||||||||
| Other |
|
|
|||||||||
| Net Cash (Used in) Provided by Financing Activities |
(
|
|
|||||||||
| Effect of exchange rate changes on cash |
|
(
|
|||||||||
| (Decrease) Increase in Cash, Cash Equivalents and Restricted Cash |
(
|
|
|||||||||
| Cash, cash equivalents and restricted cash at beginning of year |
|
|
|||||||||
| Cash, Cash Equivalents and Restricted Cash at End of Period | $ |
|
$ |
|
|||||||
See accompanying Notes to the Consolidated Financial Statements.
3
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(Dollars in millions, except per share data)
Note 1 - Basis of Presentation
The accompanying Consolidated Financial Statements (unaudited) for The Timken Company (the "Company" or "Timken") have been prepared in accordance with the instructions to Form 10-Q and do not include all of the information and notes required by the accounting principles generally accepted in the United States ("U.S. GAAP") for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) and disclosures considered necessary for a fair presentation have been included. For further information, refer to the Consolidated Financial Statements and accompanying Notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.
The Company previously classified intangible asset amortization expense within cost of products sold in the Company's Consolidated Statements of Income. Intangible asset amortization expense is now classified separately. The 2022 presentation has been revised to conform to the 2023 presentation resulting in a reduction in the cost of products sold for the three months ended March 31, 2022.
Note 2 - Significant Accounting Policies
The Company's significant accounting policies are detailed in "
Note 1 - Significant Accounting Policies"
of the Annual Report on Form 10-K for the year ended December 31, 2022.
Recent Accounting Pronouncements:
New Accounting Guidance Adopted:
In September 2022, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2022-04, "Liabilities - Supplier Finance Programs (Subtopic 405-50)." ASU 2022-04 is intended to establish disclosures that enhance the transparency of a supplier finance program used by an entity in connection with the purchase of goods and services. Supplier finance programs, which also may be referred to as reverse factoring, payables finance or structured payables arrangements, allow a buyer to offer its suppliers the option for access to payment in advance of an invoice due date, which is paid by a third-party finance provider or intermediary. Under the guidance, a buyer in a supplier finance program would disclose qualitative and quantitative information about its supplier finance programs. The new guidance is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. Early adoption is permitted. Refer to
Note 12 - Supply Chain Financing
in
the Notes to the Consolidated Financial Statements for additional information.
4
Note 3 - Acquisitions and Divestitures
Acquisitions:
On January 31, 2023, the Company acquired the assets of American Roller Bearing Company ("ARB"), a North Carolina-based manufacturer of industrial bearings. ARB, which boasts a large U.S. installed base and strong aftermarket business, operates manufacturing facilities in Hiddenite and Morganton, North Carolina. The total purchase price for this acquisition was $
32.0
million, including $
0.5
million of the purchase price that was held back for the post-closing settlement of working capital. ARB generated sales of approximately $
35
million in 2022 and the transaction was funded with cash on hand. Results for ARB are reported in the Engineered Bearings segment.
The following table presents the purchase price allocation at fair value for the ARB acquisition as of March 31, 2023.
|
Initial Purchase
Price Allocation |
|||||
| Assets: | |||||
| Accounts receivable | $ |
|
|||
| Inventories |
|
||||
| Other current assets |
|
||||
| Property, plant and equipment |
|
||||
| Other intangible assets |
|
||||
| Total assets acquired | $ |
|
|||
| Liabilities: | |||||
| Accounts payable, trade | $ |
|
|||
| Salaries, wages and benefits |
|
||||
| Other current liabilities |
|
||||
| Total liabilities assumed | $ |
|
|||
| Net assets acquired | $ |
|
|||
In determining the fair value of the amounts above, the Company utilized various forms of the income, cost and market approaches depending on the asset or liability being valued. The estimation of fair value required judgement related to future net cash flows, discount rates, competitive trends, market comparisons and other factors. Inputs were generally determined by taking into account independent appraisals and historical data, supplemented by current and anticipated market conditions.
The amounts in the table above represent the preliminary purchase price allocation for ARB. This purchase price allocation, including the residual amount allocated to goodwill or the recognition of a bargain purchase price gain, is based on preliminary information and is subject to change as additional information concerning final asset and liability valuations are obtained and management completes its reassessment of the measurement period procedures based on the results of the preliminary valuation. As of March 31, 2023, no elements of the purchase price allocation have been finalized. During the applicable measurement period, the Company will adjust assets and liabilities if new information is obtained about facts and circumstances that existed as of the acquisition date that, if known, would have resulted in revised estimated values of those assets or liabilities as of that date. The effect of measurement period adjustments to the estimated fair values will be reflected as if the adjustments has been completed on the acquisition date.
On November 4, 2022, the Company completed the acquisition of GGB Bearing Technology ("GGB"), a global technology and market leader of premium engineered metal-polymer plain bearings, for $
302.5
million, net of cash acquired of $
19.2
million, subject to customary post-closing adjustments. GGB's revenue was approximately $
200
million for the full year 2022. GGB's products are used mainly in industrial applications, including pumps and compressors, HVAC, off-highway, energy, material handling and aerospace. With manufacturing facilities across the United States, Europe and China, GGB employs approximately
900
people and has a global engineering, distribution and sales footprint. Results for GGB are reported in the Engineered Bearings segment.
On May 31, 2022, the Company completed the acquisition of Spinea, s.r.o. ("Spinea"), a European technology leader and manufacturer of highly engineered cycloidal reduction gears and actuators, with full year 2022 sales of approximately $
40
million. Spinea’s solutions primarily serve high-precision automation and robotics applications in the factory automation platform. Spinea is located in Presov, Slovakia. The purchase price for this acquisition was $
151.2
million, net of cash acquired of $
0.2
million, subject to customary post-closing adjustments. Results for Spinea are reported in the Industrial Motion segment.
5
Note 3 - Acquisitions and Divestitures (continued)
The following table presents the updated purchase price allocation at fair value, net of cash acquired, for the 2022 acquisitions, as of March 31, 2023:
| Initial Purchase Price Allocation | Adjustments | Updated Purchase Price Allocation | |||||||||
| Assets: | |||||||||||
| Accounts receivable | $ |
|
$ | — | $ |
|
|||||
| Inventories |
|
(
|
|
||||||||
| Other current assets |
|
— |
|
||||||||
| Property, plant and equipment |
|
(
|
|
||||||||
| Goodwill |
|
(
|
|
||||||||
| Other intangible assets |
|
(
|
|
||||||||
| Other assets |
|
|
|
||||||||
| Total assets acquired | $ |
|
$ |
(
|
$ |
|
|||||
| Liabilities: | |||||||||||
| Accounts payable, trade | $ |
|
$ |
(
|
$ |
|
|||||
| Salaries, wages and benefits |
|
— |
|
||||||||
| Income taxes payable |
|
— |
|
||||||||
| Other current liabilities |
|
(
|
|
||||||||
| Accrued pension benefits |
|
— |
|
||||||||
| Deferred income taxes |
|
— |
|
||||||||
| Other non-current liabilities |
|
— |
|
||||||||
| Total liabilities assumed | $ |
|
$ |
(
|
$ |
|
|||||
| Net assets acquired | $ |
|
$ |
(
|
$ |
|
|||||
The above purchase price allocation, including the residual amount allocated to goodwill, is based on preliminary information and is subject to change as additional information concerning final asset and liability valuations is obtained. The purchase price allocation for Spinea is preliminary pending the continued evaluation of operating leases, which is expected to be finalized during the second quarter of 2023. The purchase price allocation for GGB is preliminary pending the continued evaluation of certain working capital accounts, real estate and other intangible assets, as well the related impacts on deferred income taxes. During the measurement period, the Company will adjust assets and liabilities if new information is obtained about facts and circumstances that existed as of the acquisition date that, if known, would have resulted in revised estimated values of those assets or liabilities as of that date. The effect of measurement period adjustments to the estimated fair values will be reflected as if the adjustments had been completed on the acquisition date.
On April 4, 2023, the Company acquired Leonardo Top S.a.r.l. ("Nadella"), a leading European manufacturer of linear guides, telescopic rails, actuators and systems and other specialized industrial motion solutions, from ICG plc. Nadella operates manufacturing facilities in Europe and China and reported revenue of approximately €
100
million in 2022.
Divestitures:
6
Note 4 - Segment Information
The primary measurement used by management to measure the financial performance of each segment is earnings before interest, taxes, depreciation and amortization ("EBITDA").
Effective January 1, 2023, the Company began operating under new reportable segments. The Company’s
two
reportable segments are Engineered Bearings and Industrial Motion. Segment results for 2022 have been revised to conform to the 2023 presentation of segments.
|
Three Months Ended
March 31, |
|||||||||||
| 2023 | 2022 | ||||||||||
| Net sales: | |||||||||||
| Engineered Bearings | $ |
|
$ |
|
|||||||
| Industrial Motion |
|
|
|||||||||
| Net sales | $ |
|
$ |
|
|||||||
| Segment EBITDA: | |||||||||||
| Engineered Bearings | $ |
|
$ |
|
|||||||
| Industrial Motion |
|
|
|||||||||
| Total EBITDA, for reportable segments | $ |
|
$ |
|
|||||||
| Unallocated corporate expense |
(
|
(
|
|||||||||
|
Corporate pension and other postretirement benefit related income (expense)
(1)
|
|
(
|
|||||||||
| Depreciation and amortization |
(
|
(
|
|||||||||
| Interest expense |
(
|
(
|
|||||||||
| Interest income |
|
|
|||||||||
| Income before income taxes | $ |
|
$ |
|
|||||||
(1)
Corporate pension and other postretirement benefit related expense represents actuarial (losses) and gains that resulted from the remeasurement of pension and other postretirement plan assets and obligations as a result of changes in assumptions or experience.
|
March 31,
2023 |
December 31, 2022 | ||||||||||
| Assets by Segment: | |||||||||||
| Engineered Bearings | $ |
|
$ |
|
|||||||
| Industrial Motion |
|
|
|||||||||
|
Corporate
(2)
|
|
|
|||||||||
| $ |
|
$ |
|
||||||||
(2)
Corporate assets include corporate buildings and cash and cash equivalents.
7
Note 5 - Revenue
The following table presents details deemed most relevant to the users of the financial statements about total revenue for the three months ended March 31, 2023 and 2022:
| Three Months Ended | Three Months Ended | |||||||||||||||||||
| March 31, 2023 | March 31, 2022 | |||||||||||||||||||
| Engineered Bearings | Industrial Motion | Total | Engineered Bearings | Industrial Motion | Total | |||||||||||||||
| United States | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||
| Americas excluding the United States |
|
|
|
|
|
|
||||||||||||||
| Europe / Middle East / Africa |
|
|
|
|
|
|
||||||||||||||
| China |
|
|
|
|
|
|
||||||||||||||
| Asia-Pacific excluding China |
|
|
|
|
|
|
||||||||||||||
| Net sales | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||
When reviewing revenue by sales channel, the Company separates net sales to original equipment manufacturers ("OEMs") from sales to distributors and end users. The following table presents the approximate percent of revenue by sales channel for the three months ended March 31, 2023 and 2022:
| Three Months Ended | Three Months Ended | |||||||
| Revenue by sales channel | March 31, 2023 | March 31, 2022 | ||||||
| Original equipment manufacturers |
|
|
||||||
| Distribution/end users |
|
|
||||||
In addition to disaggregating revenue by segment, geography and by sales channel as shown above, the Company believes information about the timing of transfer of goods or services, type of customer and distinguishing service revenue from product sales is also relevant. During the three months ended March 31, 2023 and March 31, 2022, approximately
8
%
and
9
%, respectively,
of total net sales were recognized on an over-time basis because of the continuous transfer of control to the customer, with the remainder recognized as of a point in time. Approximately
4
% and
5
% of total net sales represented service revenue during the three months ended March 31, 2023 and March 31, 2022, respectively. Finally, business with the United States ("U.S.") government or its contractors represented approximately
5
% and
7
% of total net sales during each of the three months ended March 31, 2023 and March 31, 2022, respectively.
Remaining Performance Obligations:
Remaining performance obligations represent the transaction price of orders meeting the definition of a contract for which work has not been performed and excludes unexercised contract options. Performance obligations having a duration of more than one year are concentrated in contracts for certain products and services provided to the U.S. government or its contractors. The aggregate amount of the transaction price allocated to remaining performance obligations for such contracts with a duration of more than one year was approximately $
126.0
million
a
t March 31, 2023.
8
Note 5 - Revenue
(continued)
Unbilled Receivables:
The following table contains a rollforward of unbilled receivables for the three months ended March 31, 2023 and the twelve months ended December 31, 2022:
|
March 31,
2023 |
December 31,
2022 |
|||||||
| Beginning balance, January 1 | $ |
|
$ |
|
||||
| Additional unbilled revenue recognized |
|
|
||||||
| Less: amounts billed to customers |
(
|
(
|
||||||
| Less: unbilled receivables reclassified to assets held for sale |
|
(
|
||||||
| Ending balance | $ |
|
$ |
|
||||
There were
no
impairment losses recorded on unbilled receivables for the three months ended March 31, 2023 and the twelve months ended December 31, 2022.
Deferred Revenue:
The following table contains a rollforward of deferred revenue for the three months ended March 31, 2023 and the twelve months ended December 31, 2022:
|
March 31,
2023 |
December 31,
2022 |
|||||||
| Beginning balance, January 1 | $ |
|
$ |
|
||||
| Revenue (cash) received in advance |
|
|
||||||
| Less: revenue recognized |
(
|
(
|
||||||
| Ending balance | $ |
|
$ |
|
||||
Note 6 - Income Taxes
The Company's provision for income taxes in interim periods is computed by applying the estimated annual effective tax rates to income or loss before income taxes for the period. In addition, non-recurring or discrete items are recorded during the period(s) in which they occur.
|
Three Months Ended
March 31, |
||||||||
| 2023 | 2022 | |||||||
| Provision for income taxes | $ |
|
$ |
|
||||
| Effective tax rate |
|
% |
|
% | ||||
Income tax expense for the three months ended March 31, 2023 was calculated using forecasted multi-jurisdictional annual effective tax rates to determine a blended annual effective tax rate. The effective tax rate differs from the U.S. federal statutory rate of 21% primarily due to the projected mix of earnings in international jurisdictions with relatively higher tax rates.
The effective tax rate of
25.3
% for the three months ended March 31, 2023 was higher than the effective tax rate for the three months ended March 31, 2022 primarily due to an increase in the mix of earnings in international jurisdictions with relatively higher tax rates.
9
Note 7 - Earnings Per Share
The following table sets forth the reconciliation of the numerator and the denominator of basic earnings per share and diluted earnings per share for the three months ended March 31, 2023 and 2022, respectively:
|
Three Months Ended
March 31, |
|||||||||||
| 2023 | 2022 | ||||||||||
| Numerator: | |||||||||||
| Net income attributable to The Timken Company | $ |
|
$ |
|
|||||||
| Denominator: | |||||||||||
| Weighted average number of shares outstanding - basic |
|
|
|||||||||
| Effect of dilutive securities: | |||||||||||
|
Stock options and awards - based on the treasury
stock method |
|
|
|||||||||
|
Weighted average number of shares outstanding assuming
dilution of stock options and awards |
|
|
|||||||||
| Basic earnings per share | $ |
|
$ |
|
|||||||
| Diluted earnings per share | $ |
|
$ |
|
|||||||
The dilutive effect of performance-based restricted stock units are included once they meet minimum performance thresholds. The dilutive effect of stock options includes all outstanding stock options except stock options that are considered antidilutive. Stock options are antidilutive when the exercise price exceeds the average market price of the Company’s common shares during the periods presented. There were
no
antidilutive stock options outstanding during the three months ended March 31, 2023 and 2022.
Note 8 - Inventories
The components of inventories at March 31, 2023 and December 31, 2022 were as follows:
|
March 31,
2023 |
December 31,
2022 |
||||||||||
| Manufacturing supplies | $ |
|
$ |
|
|||||||
| Raw materials |
|
|
|||||||||
| Work in process |
|
|
|||||||||
| Finished products |
|
|
|||||||||
| Subtotal |
|
|
|||||||||
| Allowance for obsolete and surplus inventory |
(
|
(
|
|||||||||
| Total inventories, net | $ |
|
$ |
|
|||||||
Inventories are valued at net realizable value, with approximately
60
% valued on the first-in, first-out ("FIFO") method and the remaining
40
% valued on the last-in, first-out ("LIFO") method. The majority of the Company's domestic inventories are valued on the LIFO method. The Company's international inventories are valued on the FIFO method.
The LIFO reserve at March 31, 2023 and December 31, 2022 was $
234.2
million and $
235.4
million, respectively. An actual valuation of the inventory under the LIFO method can be made only at the end of each year based on the inventory levels and costs at that time. Accordingly, interim LIFO calculations are based on management’s estimates of expected year-end inventory levels and costs. Because these calculations are subject to many factors beyond management’s control, annual results may differ from interim results as they are subject to the final year-end LIFO inventory valuation.
10
Note 9 - Goodwill and Other Intangible Assets
The Company tests goodwill and indefinite-lived intangible assets for impairment at least annually, performing its annual impairment test as of October 1
st
. Furthermore, goodwill and indefinite-lived intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying value may not be recoverable.
In connection with the adoption of new reportable segments, goodwill was reallocated to new reporting units based on relative fair value at the reporting unit level. The Engineered Bearings segment has
one
reporting unit and the Industrial Motion segment has
six
reporting units.
The changes in the carrying amount of goodwill for the three months ended March 31, 2023 were as follows:
| Engineered Bearings | Industrial Motion | Total | |||||||||
| Beginning balance | $ |
|
$ |
|
$ |
|
|||||
| Impairment loss |
|
(
|
(
|
||||||||
| Foreign currency translation adjustments and other changes |
(
|
|
|
||||||||
| Ending balance | $ |
|
$ |
|
$ |
|
|||||
During the first quarter of 2023, the Company reviewed goodwill for impairment for its reporting units due to the change in reporting segments that went into effect January 1, 2023. The Company utilizes both an income approach and a market approach in testing goodwill for impairment. The Company utilized updated forecasts for the income approach as part of the goodwill impairment review. Based on the earnings and cash flow forecasts for the Belts & Chain reporting unit within the Industrial Motion segment, the Company determined that the reporting unit could not support the carrying value of its goodwill. As a result, the Company recorded a pretax impairment loss of $
28.3
million during the first quarter of 2023, which was reported in impairment and restructuring charges on the Consolidated Statement of Income.
The following table displays intangible assets as of March 31, 2023 and December 31, 2022:
| Balance at March 31, 2023 | Balance at December 31, 2022 | |||||||||||||||||||
|
Gross
Carrying Amount |
Accumulated
Amortization |
Net
Carrying Amount |
Gross
Carrying Amount |
Accumulated
Amortization |
Net
Carrying Amount |
|||||||||||||||
|
Intangible assets
subject to amortization: |
||||||||||||||||||||
| Customer relationships | $ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
|
||||||||
| Technology and know-how |
|
(
|
|
|
(
|
|
||||||||||||||
| Trade names |
|
(
|
|
|
(
|
|
||||||||||||||
| Capitalized software |
|
(
|
|
|
(
|
|
||||||||||||||
| Other |
|
(
|
|
|
(
|
|
||||||||||||||
| $ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||
| Intangible assets not subject to amortization: | ||||||||||||||||||||
| Trade names | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||
| FAA air agency certificates |
|
|
|
|
||||||||||||||||
| $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||
| Total intangible assets | $ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
|
||||||||
11
Note 10 - Other Current Liabilities
The following table displays other current liabilities as of March 31, 2023 and December 31, 2022:
| (Dollars in millions) |
March 31,
2023 |
December 31,
2022 |
||||||
| Sales rebates | $ |
|
$ |
|
||||
| Deferred revenue |
|
|
||||||
| Product warranty |
|
|
||||||
| Operating lease liabilities |
|
|
||||||
| Current derivative liability |
|
|
||||||
| Taxes other than income and payroll taxes |
|
|
||||||
| Freight and duties |
|
|
||||||
| Interest |
|
|
||||||
| Professional fees |
|
|
||||||
| Restructuring |
|
|
||||||
| Other |
|
|
||||||
| Total other current liabilities | $ |
|
$ |
|
||||
12
Note 11 - Financing Arrangements
Short-term debt at March 31, 2023 and December 31, 2022 was as follows:
|
March 31,
2023 |
December 31,
2022 |
|||||||
|
Variable-rate Accounts Receivable Facility with an interest rate of
|
$ |
|
$ |
|
||||
|
Borrowings under lines of credit for certain of the Company’s foreign subsidiaries with various banks with interest rates ranging from
|
|
|
||||||
| Short-term debt | $ |
|
$ |
|
||||
The Company has a $
100
million Amended and Restated Asset Securitization Agreement (the "Accounts Receivable Facility"), which matures on November 30, 2024. Under the terms of the Accounts Receivable Facility, the Company sells, on an ongoing basis, certain domestic trade receivables to Timken Receivables Corporation, a wholly-owned consolidated subsidiary that, in turn, uses the trade receivables to secure borrowings that are funded through a vehicle that issues commercial paper in the short-term market. Borrowings under the Accounts Receivable Facility may be limited to certain borrowing base limitations; however, availability under the Accounts Receivable Facility was not reduced by any such borrowing base limitations at March 31, 2023. As of March 31, 2023, there were $
100.0
million in outstanding borrowings under the Accounts Receivable Facility, which reduced the availability under this facility to
zero
. $
7.1
million of the outstanding borrowings under the Accounts Receivable Facility was classified as short-term at March 31, 2023, which reflects the Company's expectations over the next 12 months relative to the minimum borrowing base. The cost of this facility, which is the prevailing commercial paper rate plus facility fees, is considered a financing cost and is included in interest expense in the Consolidated Statements of Income.
Lines of credit for certain of the Company's foreign subsidiaries provide for short-term borrowings up to $
237.4
million in the aggregate. Most of these lines of credit are uncommitted. At March 31, 2023, the Company’s foreign subsidiaries had borrowings outstanding of $
38.7
million and bank guarantees of $
3.7
million, which reduced the aggregate availability under these facilities to $
195.0
million.
Long-term debt at March 31, 2023 and December 31, 2022 was as follows:
|
March 31,
2023 |
December 31,
2022 |
|||||||
|
Variable-rate Senior Credit Facility with an average interest rate on U.S. Dollar of
|
$ |
|
$ |
|
||||
|
Variable-rate Accounts Receivable Facility with an interest rate of
|
|
|
||||||
|
Variable-rate Term Loan
(1)
, maturing on December 5, 2027, with an interest rate of
|
|
|
||||||
|
Fixed-rate Senior Unsecured Notes
(1)
, maturing on September 1, 2024, with an interest rate of
|
|
|
||||||
|
Fixed-rate Euro Senior Unsecured Notes
(1)
, maturing on September 7, 2027, with an interest rate of
|
|
|
||||||
|
Fixed-rate Senior Unsecured Notes
(1)
, maturing on December 15, 2028, with an interest rate of
|
|
|
||||||
|
Fixed-rate Medium-Term Notes, Series A
(1)
, maturing at various dates through May 2028, with interest rates ranging from
|
|
|
||||||
|
Fixed-rate Senior Unsecured Notes
(1)
, maturing on April 1, 2032, with an interest rate of
|
|
|
||||||
|
Fixed-rate Euro Bank Loan, maturing on June 30, 2033, with an interest rate of
|
|
|
||||||
| Other |
|
|
||||||
| Total debt | $ |
|
$ |
|
||||
| Less: current maturities |
|
|
||||||
| Long-term debt | $ |
|
$ |
|
||||
13
Note 11 - Financing Arrangements (continued)
On December 5, 2022, the Company entered into the Fifth Amended and Restated Credit Agreement ("Credit Agreement"), which is comprised of the $
750.0
million unsecured revolving credit facility ("Senior Credit Facility") and a $
400.0
million unsecured term loan facility ("2027 Term Loan") that each mature on December 5, 2027. The Credit Agreement amended and restated the Company's previous revolving credit agreement that was set to mature on June 25, 2024, and replaced the $
350.0
million term loan that was set to mature on September 11, 2023 ("2023 Term Loan"). The Credit Agreement also replaced interest rates based on LIBOR with interest rates based on Secured Overnight Financing Rate ("SOFR"). At March 31, 2023, the Company had $
63.6
million of outstanding borrowings under the Senior Credit Facility, which reduced the availability under this facility to $
686.4
million. The Credit Agreement has
two
financial covenants: a consolidated leverage ratio and a consolidated interest coverage ratio.
On March 28, 2022, the Company issued fixed-rate unsecured senior notes ("2032 Notes") in the aggregate principal amount of $
350
million with an interest rate of
4.125
%, maturing on April 1, 2032. Proceeds from the 2032 Notes were used for general corporate purposes, which included the repayment of borrowings under the Senior Credit Facility and the Accounts Receivable Facility outstanding at the time of issuance.
At March 31, 2023, the Company was in full compliance with all applicable covenants on its outstanding debt.
In the ordinary course of business, the Company utilizes standby letters of credit issued by financial institutions to guarantee certain obligations, most of which relate to insurance contracts. At March 31, 2023, outstanding letters of credit totaled $
52.0
million, most with expiration dates within 12 months.
The maturities of long-term debt (including $
3.5
million of finance leases) subsequent to March 31, 2023 are as follows:
| Year | |||||
| 2023 | $ |
|
|||
| 2024 |
|
||||
| 2025 |
|
||||
| 2026 |
|
||||
| 2027 |
|
||||
| 2028 |
|
||||
| Thereafter |
|
||||
The table above excludes $
11.4
million of unamortized premiums and fees that are netted against long-term debt at March 31, 2023.
14
Note 12 - Supply Chain Financing
The Company offers a supplier finance program with two different financial institutions where suppliers may receive early payment from the financial institutions on invoices issued to the Company. The Company and each financial institution entered into arrangements providing for the Company to pay the financial institution per the terms of any supplier invoice paid early under the program and to pay an annual fee for the supplier finance platform subscription and related support. The Company and the financial institutions may terminate participation in the program with
90
days’ written notice. The supplier finance programs are unsecured and are not guaranteed by the Company. The financial institutions enter into separate arrangements with suppliers directly to participate in the program. The Company does not determine the terms or conditions of such arrangements or participate in the transactions between the suppliers and the financial institutions.
The supplier invoice terms under the program typically require payment in full within
90
days of the invoice date.
The following table is a rollforward of the outstanding obligations for the Company’s supplier finance program for the three months ended March 31, 2023:
|
March 31,
2023 |
|||||
| Confirmed obligations outstanding, January 1 | $ |
|
|||
| Invoices confirmed |
|
||||
| Confirmed invoices paid |
(
|
||||
| Confirmed obligations outstanding, ending balance | $ |
|
|||
The obligations outstanding at March 31, 2023 were included in accounts payable, trade on the Consolidated Balance Sheet.
15
Note 13 - Contingencies
The Company and certain of its subsidiaries have been identified as potentially responsible parties for investigation and remediation under the Comprehensive Environmental Response, Compensation and Liability Act, known as the Superfund, or similar state laws with respect to certain sites. Claims for investigation and remediation have been asserted against numerous other entities, which are believed to be financially solvent and are expected to fulfill their proportionate share of the obligation.
On December 28, 2004, the United States Environmental Protection Agency (“USEPA”) sent Lovejoy, LLC. ("Lovejoy") a Special Notice Letter that identified Lovejoy as a potentially responsible party, together with at least 14 other companies, at the Ellsworth Industrial Park Site, Downers Grove, DuPage County, Illinois (the “Site”). The Company acquired Lovejoy in 2016. Lovejoy’s Downers Grove property is situated within the Ellsworth Industrial Complex. The USEPA and the Illinois Environmental Protection Agency (“IEPA”) allege there have been one or more releases or threatened releases of hazardous substances, allegedly including, but not limited to, a release or threatened release on or from Lovejoy's property, at the Site. The relief sought by the USEPA and IEPA includes further investigation and potential remediation of the Site and reimbursement of response costs. Lovejoy’s allocated share of past and future costs related to the Site, including for investigation and/or remediation, could be significant. All previously pending property damage and personal injury lawsuits against Lovejoy related to the Site were settled or dismissed prior to our acquisition of Lovejoy.
The Company had total environmental accruals of
$
4.7
million
and $
4.8
million for various known environmental matters that are probable and reasonably estimable at March 31, 2023
and
December 31, 2022, respectively, which includes the Lovejoy matter described above. These accruals were recorded based upon the best estimate of costs to be incurred in light of the progress made in determining the magnitude of remediation costs, the timing and extent of remedial actions required by governmental authorities and the amount of the Company’s liability in proportion to other responsible parties.
Product Warranties:
In addition to the contingencies above, the Company provides limited warranties on certain of its products. The product warranty liability included in "Other current liabilities" on the Consolidated Balance Sheets was
$
25.4
million and $
23.5
million at March 31, 2023 and December 31, 2022, respectively. The balances at the end of each respective period represent the best estimates of costs for future claims for products that are still under warranty. The increase in the liability for the first three months of 2023 primarily relates to additional accruals for certain products sold into the automotive and renewable energy sectors. Accrual estimates are based on actual claims and expected trends that continue to mature. The Company is currently evaluating claims raised by certain customers with respect to the performance of bearings sold into the wind energy sector. Management believes that the outcome of these claims will not have a material effect on the Company's consolidated financial position; however, the effect of any such outcome may be material to the results of operations of any particular period in which costs in excess of amounts provided, if any, are recognized.
The following is a rollforward of the consolidated product warranty accrual for the three months ended March 31, 2023 and twelve months ended December 31, 2022:
|
March 31,
2023 |
December 31,
2022 |
|||||||
| Beginning balance, January 1 | $ |
|
$ |
|
||||
| Expense |
|
|
||||||
| Payments |
(
|
(
|
||||||
| Ending balance | $ |
|
$ |
|
||||
16
Note 14 - Equity
The following tables present the changes in the components of equity for the three months ended March 31, 2023 and 2022, respectively:
| The Timken Company Shareholders | |||||||||||||||||||||||
| Total |
Stated
Capital |
Other
Paid-In Capital |
Retained Earnings |
Accumulated
Other Comprehensive Loss |
Treasury
Stock |
Non
controlling Interest |
|||||||||||||||||
| Balance at December 31, 2022 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||
| Net income |
|
|
|
||||||||||||||||||||
| Foreign currency translation adjustment |
|
|
|
||||||||||||||||||||
|
Pension and other postretirement liability
adjustments (net of income tax benefit
of $
|
(
|
(
|
|||||||||||||||||||||
|
Change in fair value of derivative financial
instruments, net of reclassifications |
(
|
(
|
|||||||||||||||||||||
|
Dividends - $
|
(
|
(
|
|||||||||||||||||||||
| Stock-based compensation expense |
|
|
|||||||||||||||||||||
| Stock purchased at fair market value |
(
|
(
|
|||||||||||||||||||||
| Stock option exercise activity |
|
|
|||||||||||||||||||||
|
Payments related to tax withholding for
stock-based compensation |
(
|
(
|
|||||||||||||||||||||
| Balance at March 31, 2023 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||
| The Timken Company Shareholders | |||||||||||||||||||||||
| Total |
Stated
Capital |
Other
Paid-In Capital |
Retained Earnings |
Accumulated
Other Comprehensive Income |
Treasury
Stock |
Non
controlling Interest |
|||||||||||||||||
| Balance at December 31, 2021 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||
| Net income |
|
|
|
||||||||||||||||||||
| Foreign currency translation adjustment |
(
|
(
|
(
|
||||||||||||||||||||
|
Pension and other postretirement liability
adjustments (net of income tax benefit
of $
|
(
|
(
|
|||||||||||||||||||||
|
Change in fair value of derivative financial
instruments, net of reclassifications |
|
|
|||||||||||||||||||||
|
Dividends - $
|
(
|
(
|
|||||||||||||||||||||
| Stock-based compensation expense |
|
|
|||||||||||||||||||||
| Stock purchased at fair market value |
(
|
(
|
|||||||||||||||||||||
| Stock option exercise activity |
|
|
|||||||||||||||||||||
|
Payments related to tax withholding for
stock-based compensation |
(
|
(
|
|||||||||||||||||||||
| Balance at March 31, 2022 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||
17
Note 15 - Impairment and Restructuring Charges
Impairment and restructuring charges by segment are comprised of the following:
For the three months ended March 31, 2023:
| Engineered Bearings | Industrial Motion | Total | |||||||||
| Impairment charges | $ |
|
$ |
|
$ |
|
|||||
| Severance and related benefit costs |
|
(
|
|
||||||||
| Total | $ |
|
$ |
|
$ |
|
|||||
| Engineered Bearings | Industrial Motion | Total | |||||||||
| Severance and related benefit costs | $ |
|
$ |
(
|
$ |
|
|||||
| Exit costs |
|
|
|
||||||||
| Total | $ |
|
$ |
(
|
$ |
|
|||||
Engineered Bearings:
On January 16, 2023, the Company announced the closure of its bearing plant in Gaffney, South Carolina. The Company expects to transfer its remaining operations to other bearing manufacturing facilities in North America. The closure of this facility is expected to occur by the end of the fourth quarter of 2023 and is expected to affect approximately
225
employees. The Company expects to incur approximately $
10
million to $
12
million of pretax costs in total related to this closure. During the three months ended March 31, 2023, the Company recorded severance and related benefits of $
0.8
million related to this closure. T
he Company incurred cumulative pretax costs related to this closure of $
2.0
million as of March 31, 2023, including rationalization costs recorded in cost of products sold.
On July 19, 2021, the Company announced the closure of its bearing manufacturing facility in Villa Carcina, Italy. The Company transferred the manufacturing of its single-row tapered roller bearing production to other bearing facilities in Europe, Asia and the United States. The Company completed the closure of the facility on October 31, 2022, and it affected approximately
110
employees. During the three months ended March 31, 2022, the Company recorded severance and related benefits of $
0.4
million and exit costs of $
0.6
million related to this closure. The Company incurred cumulative pretax costs related to this closure of $
9.8
million as of March 31, 2023, including rationalization costs recorded in cost of products sold. On November 1, 2022, the Company completed the sale of this facility.
Industrial Motion:
During the third quarter of 2022, the Company announced certain organizational changes, which included the appointment of executive leaders for its Engineered Bearings and Industrial Motion product groups. After evaluating the impact from the organizational changes and revising segment results through the balance of 2022, the Company concluded that it will operate under
two
new reportable segments, Engineered Bearings and Industrial Motion, effective January 1, 2023. In conjunction with this change in segmented results, the Company had to reallocate goodwill to new reporting units under these
two
segments. In addition, the Company had to review goodwill for impairment under these new reporting units. As a result of this goodwill impairment review, the Company recognized a pretax goodwill impairment loss of
$
28.3
million
during the three months ended March 31, 2023.
18
Note 15 - Impairment and Restructuring Charges (continued)
On February 4, 2020, the Company announced the closure of its chain manufacturing facility in Indianapolis, Indiana. This facility was part of the Diamond Chain Company ("Diamond Chain") acquisition completed on April 1, 2019. The Company transferred the majority of its Diamond Chain product line to its chain manufacturing facility in Fulton, Illinois. The chain plant is expected to cease operations by the end of April 2023 and is expected to affect approximately
240
employees. The Company expects to hire approximately
130
full-time positions in Fulton, Illinois and expects to incur approximately $
12
million to $
15
million of expenses related to this closure. The Company has incurred cumulative pretax costs related to this closure of $
14.4
million as of March 31, 2023, including rationalization costs recorded in cost of products sold.
Consolid
ated Restructuring Accrual:
The following is a rollforward of the consolidated restructuring accrual for the three months ended March 31, 2023 and twelve months ended December 31, 2022:
|
March 31,
2023 |
December 31,
2022 |
|||||||
| Beginning balance, January 1 | $ |
|
$ |
|
||||
| Expense |
|
|
||||||
| Payments |
(
|
(
|
||||||
| Ending balance | $ |
|
$ |
|
||||
The restructuring accrual at March 31, 2023 and December 31, 2022 was included in other current liabilities on the Consolidated Balance Sheets.
19
Note 16 - Retirement Benefit Plans
The following table sets forth the net periodic benefit cost for the Company’s defined benefit pension plans. The amounts for the three months ended March 31, 2023 are based on calculations prepared by the Company's actuaries and represent the Company’s best estimate of that period’s proportionate share of the amounts to be recorded for the year ending December 31, 2023.
| U.S. Plans | International Plans | Total | ||||||||||||||||||
|
Three Months Ended
March 31, |
Three Months Ended
March 31, |
Three Months Ended
March 31, |
||||||||||||||||||
| 2023 | 2022 | 2023 | 2022 | 2023 | 2022 | |||||||||||||||
| Components of net periodic benefit cost (credit): | ||||||||||||||||||||
| Service cost | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||
| Interest cost |
|
|
|
|
|
|
||||||||||||||
| Expected return on plan assets |
(
|
(
|
(
|
(
|
(
|
(
|
||||||||||||||
| Amortization of prior service cost |
|
|
|
|
|
|
||||||||||||||
|
Recognition of net actuarial (gains)
losses |
(
|
|
|
|
(
|
|
||||||||||||||
| Net periodic benefit cost (credit) | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
||||||||
For the three months ended March 31, 2023, lump sum payments related to new retirees exceeded annual interest and service costs for one of the Company's U.S. defined benefit pension plans, triggering a remeasurement of assets and obligations for this plan. As a result of this remeasurement, the Company recognized a net actuarial gain ("mark-to-market charges") of $
0.9
million during the three months ended March 31, 2023.
For the three months ended March 31, 2022, the Company expected to make lump sum payments related to new retirees in excess of annual interest and service costs for one of the Company's U.S. defined benefit pension plans. This expectation triggered a remeasurement of assets and obligations for this plan. As a result of this remeasurement, the Company recognized a net actuarial loss of $
2.6
million during the three months ended March 31, 2022.
Note 17 - Other Postretirement Benefit Plans
The following table sets forth the net periodic benefit cost for the Company’s other postretirement benefit plans. The amounts for the three months ended March 31, 2023 are based on calculations prepared by the Company's actuaries and represent the Company’s best estimate of that period’s proportionate share of the amounts to be recorded for the year ending December 31, 2023.
|
Three Months Ended
March 31, |
|||||||||||
| 2023 | 2022 | ||||||||||
| Net periodic benefit credit: | |||||||||||
| Interest cost | $ |
|
$ |
|
|||||||
| Amortization of prior service credit |
(
|
(
|
|||||||||
| Net periodic benefit credit | $ |
(
|
$ |
(
|
|||||||
20
Note 18 - Accumulated Other Comprehensive Income (Loss)
The following tables present details about components of accumulated other comprehensive (loss) income for the three months ended March 31, 2023 and 2022, respectively:
| Foreign currency translation adjustments | Pension and other postretirement liability adjustments | Change in fair value of derivative financial instruments | Total | |||||||||||
| Balance at December 31, 2022 | $ |
(
|
$ |
|
$ |
|
$ |
(
|
||||||
|
Other comprehensive income (loss) before
reclassifications and income taxes |
|
|
(
|
|
||||||||||
|
Amounts reclassified from accumulated other
comprehensive (loss) income before income taxes |
|
(
|
(
|
(
|
||||||||||
| Income tax benefit |
|
|
|
|
||||||||||
|
Net current period other comprehensive income
(loss), net of income taxes |
|
(
|
(
|
|
||||||||||
| Noncontrolling interest |
(
|
|
|
(
|
||||||||||
|
Net current period other comprehensive income
(loss), net of income taxes and noncontrolling interest |
|
(
|
(
|
|
||||||||||
| Balance at March 31, 2023 | $ |
(
|
$ |
|
$ |
|
$ |
(
|
||||||
| Foreign currency translation adjustments | Pension and other postretirement liability adjustments | Change in fair value of derivative financial instruments | Total | |||||||||||
| Balance at December 31, 2021 | $ |
(
|
$ |
|
$ |
|
$ |
(
|
||||||
|
Other comprehensive (loss) income before
reclassifications and income taxes |
(
|
|
|
(
|
||||||||||
|
Amounts reclassified from accumulated other
comprehensive (loss) income before income taxes |
|
(
|
(
|
(
|
||||||||||
| Income tax benefit (expense) |
|
|
(
|
|
||||||||||
|
Net current period other comprehensive (loss)
income, net of income taxes |
(
|
(
|
|
(
|
||||||||||
| Noncontrolling interest |
|
|
|
|
||||||||||
|
Net current period other comprehensive (loss)
income, net of income taxes and noncontrolling interest |
(
|
(
|
|
(
|
||||||||||
| Balance at March 31, 2022 | $ |
(
|
$ |
|
$ |
|
$ |
(
|
||||||
Other comprehensive (loss) income before reclassifications and income taxes includes the effect of foreign currency.
21
Note 19 - Fair Value
Fair value is defined as the price that would be expected to be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The FASB provides accounting rules that classify the inputs used to measure fair value into the following hierarchy:
Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities.
Level 2 – Unadjusted quoted prices in active markets for similar assets or liabilities, or unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability.
Level 3 – Unobservable inputs for the asset or liability.
The following tables present the fair value hierarchy for those financial assets and liabilities measured at fair value on a recurring basis as of March 31, 2023 and December 31, 2022:
| March 31, 2023 | ||||||||||||||
| Total | Level 1 | Level 2 | Level 3 | |||||||||||
| Assets: | ||||||||||||||
| Cash and cash equivalents | $ |
|
$ |
|
$ |
|
$ |
|
||||||
| Cash and cash equivalents measured at net asset value |
|
|||||||||||||
| Restricted cash |
|
|
|
|
||||||||||
| Short-term investments |
|
|
|
|
||||||||||
| Interest rate swap contract |
|
|
|
|
||||||||||
| Foreign currency forward contracts |
|
|
|
|
||||||||||
| Total assets | $ |
|
$ |
|
$ |
|
$ |
|
||||||
| Liabilities: | ||||||||||||||
| Foreign currency forward contracts | $ |
|
$ |
|
$ |
|
$ |
|
||||||
| Total liabilities | $ |
|
$ |
|
$ |
|
$ |
|
||||||
| December 31, 2022 | ||||||||||||||
| Total | Level 1 | Level 2 | Level 3 | |||||||||||
| Assets: | ||||||||||||||
| Cash and cash equivalents | $ |
|
$ |
|
$ |
|
$ |
|
||||||
| Cash and cash equivalents measured at net asset value |
|
|||||||||||||
| Restricted cash |
|
|
|
|
||||||||||
| Short-term investments |
|
|
|
|
||||||||||
| Interest rate swap contract |
|
|
|
|
||||||||||
| Foreign currency forward contracts |
|
|
|
|
||||||||||
| Total assets | $ |
|
$ |
|
$ |
|
$ |
|
||||||
| Liabilities: | ||||||||||||||
| Foreign currency forward contracts | $ |
|
$ |
|
$ |
|
$ |
|
||||||
| Total liabilities | $ |
|
$ |
|
$ |
|
$ |
|
||||||
Cash and cash equivalents are highly liquid investments with maturities of three months or less when purchased and are valued at the redempti
on value. Short-term investments are investments with maturities between four months and one year, and generally are valued at amortized cost, which approximat
es fair value. A portion of the cash and cash equivalents and short-term investments are valued based on net asset value. The Company uses publicly available market interest rates to measure the fair value of its interest rate swap contracts. The Company uses publicly available foreign currency forward and spot rates to measure the fair value of its foreign currency forward contracts.
22
Note 19 - Fair Value (continued)
In addition, the Company remeasures certain assets at fair value, using Level 3 inputs, as a result of the occurrence of triggering events such as purchase accounting for acquisitions or goodwill impairment.
No other material assets w
ere measured at fair value on a nonrecurring basis during the
three
months ended March 31, 2023 and 2022, respectively.
Financial Instruments:
The Company’s financial instruments consist primarily of cash and cash equivalents, short-term investments, accounts receivable, trade accounts payable, short-term borrowings and long-term debt. Due to their short-term nature, the carrying value of cash and cash equivalents, short-term investments, accounts receivable, trade accounts payable and short-term borrowings are a reasonable estimate of their fair value. Due to the nature of fair value calculati
ons for variable-rate debt, the carrying value of the Company's long-term variable-rate debt is a reasonable estima
te of its fair value. The fair value of the Company’s long-term fixed-rate debt, based on quoted market prices, was $
1,381.7
million and $
1,353.5
million at March 31, 2023 and December 31, 2022, respectively. The carrying value of this debt was $
1,420.3
million and $
1,417.9
million at March 31, 2023 and December 31, 2022, respectively. The fair value of long-term fixed-rate debt was measured using Level 2 inputs.
The Company does not believe it has significant concentrations of risk associated with the counterparties to its financial instruments.
Note 20 - Derivative Instruments and Hedging Activities
The Company is exposed to certain risks relating to its ongoing business operations. The primary risks managed by using derivative instruments are foreign currency exchange rate risk and interest rate risk. Forward contracts on various foreign currencies are entered into in order to manage the foreign currency exchange rate risk associated with certain of the Company's commitments denominated in foreign currencies. From time to time, interest rate swaps are used to manage interest rate risk associated with the Company’s fixed and floating-rate borrowings.
The Company designates certain foreign currency forward contracts as cash flow hedges of forecasted revenues and certain interest rate hedges as cash flow hedges of fixed-rate borrowings.
On September 8, 2020, the Company entered into a $
100
million floating-to-fixed rate swap on the 2023 Term Loan, which hedges the change in the 1-month LIBOR rate between October 30, 2020 and September 11, 2023 to a fixed rate. The Company repaid the LIBOR based 2023 Term Loan on December 5, 2022 and replaced it with the SOFR based 2027 Term Loan. The Company amended the interest rate for the swap from LIBOR to SOFR commencing January 2023. The Company’s risk management objective is to hedge the risk of changes in the monthly interest expense attributable to changes in the benchmark interest rate.
On September 15, 2020, the Company designated €
54.5
million of its €
150.0
million fixed-rate senior unsecured notes, maturing on September 7, 2027 (th
e "2027 Notes"), as a hedge against its net investment in one of its European subsidiaries. The objective of the hedge transaction is to protect the net investment in the foreign operations against changes in the exchange rate between the U.S. dollar and the Euro. The net impact for the three months ended March 31, 2023, respectively, was a loss of $
0.7
million to accumulated comprehensive (loss) income with a corresponding offset to other income (expense) which partially offsets the impact of the foreign currency adjustment on the 2027 Notes.
The Company entered into $
350
million of floating-to-fixed
10-year
Treasury rate locks during the first quarter of 2022, prior to issuing the 2032 Notes. This fixed the
10-year
Treasury yield and settled at pricing of the 2032 Notes, resulting in $
6.5
million of cash proceeds received by the Company. This amount was recorded to accumulated comprehensive income and will be amortized as a reduction in interest expense over the
10-year
tenor of the 2032 Notes.
The Company does not purchase or hold any derivativ
e financial instruments for trading purposes. As of March 31, 2023 and December 31, 2022, the Company had $
674.0
million and $
635.6
million, respectively, of outstanding foreign currency forward contracts at notional value. Refer to
Note 19 - Fair Value
for the fair value disclosure of derivative financial instruments.
23
Note 20 - Derivative Instruments and Hedging Activities (continued)
Cash Flow Hedging Strategy:
For certain derivative instruments that are designated and qualify as cash flow hedges (
i.e
., hedging the exposure to variability in expected future cash flows that is attributable to a particular risk), the gain or loss on the derivative instrument is reported as a component of other comprehensive income and reclassified into earnings in the same line item associated with the forecasted transaction and in the same period or periods during which the hedged transaction affects earnings.
To protect against a reduction in the value of forecasted foreign currency cash flows resulting from export sales, the Company has instituted a foreign currency cash flow hedging program. The Company hedges portions of its forecasted cash flows denominated in foreign currencies with forward contracts. When the dollar strengthens significantly against foreign currencies, the decline in the present value of future foreign currency revenue is offset by gains in the fair value of the forward contracts designated as hedges. Co
nverse
ly, when the dollar weakens, the increase in the present value of future foreign currency cash flows is offset by losses in the fair value of the forward contracts. As of March 31, 2023 and December 31, 2022, the Company had $
79.7
million and $
82.3
million,
respectively, of outstanding foreign currency forward contracts at notional value that were classified as cash flow hedges.
The maximum length of time over which the Company hedges its exposure to the variability in future cash flows for forecast transactions is generally
eighteen months
or less.
Purpose for Derivative Instruments not designated as Hedging Instruments:
For derivative instruments that are not designated as hedging instruments, the instruments are typically forward contracts. In general, the practice is to reduce volatility by selectively hedging transaction exposures including intercompany loans, accounts payable and accounts receivable. Intercompany loans between entities with different functional currencies typically are hedged with a forward contract at the inception of the loan with a maturity date corresponding to the maturity of the loan. The revaluation of these contracts, as well as the revaluation of the underlying balance sheet items, is recorded directly to the income statement so the adjustment generally offsets the revaluation of the underlying balance sheet items to protect cash payments and reduce income statement volatility.
As of March 31, 2023 and December 31, 2022, the Company had $
594.3
million and $
553.3
million, respectively, of outstanding foreign currency forward contracts at notional value that were not d
esignated as hedging instruments.
The following table presents the impact of derivative instruments not designated as hedging instruments for the three months ended March 31, 2023 and 2022, respectively, and the related location within the Consolidated Statements of Income:
| Amount of gain or (loss) recognized in income | ||||||||||||||
|
Three Months Ended
March 31, |
||||||||||||||
| Derivatives not designated as hedging instruments: | Location of gain or (loss) recognized in income | 2023 | 2022 | |||||||||||
| Foreign currency forward contracts | Other income, net | $ |
(
|
$ |
(
|
|||||||||
24
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
(Dollars in millions, except per share data)
OVERVIEW
Introduction:
The Timken Company designs and manufactures a growing portfolio of engineered bearings and industrial motion products, and related services. With more than a century of knowledge and innovation, the Company continuously improves the reliability and efficiency of global machinery and equipment to move the world forward. The Company’s growing product and services portfolio features many strong industrial brands, such as Timken®, Philadelphia Gear®, GGB®, Drives®, Cone Drive®, Rollon®, Lovejoy®, Diamond®, BEKA®, Groeneveld®, Nadella® and Spinea®. Timken employs more than
19,000
people globally in
46
countries. The Company operates under two reportable segments: (1) Engineered Bearings and (2) Industrial Motion. The following further describes these business segments:
•
Timken’s Engineered Bearings segment features a broad range of product designs serving original equipment manufacturers (OEMs) and end-users worldwide. Timken is a leading authority on tapered roller bearings and leverages its position by applying engineering know-how and technology across its entire bearing portfolio, which includes tapered, spherical and cylindrical roller bearings; plain bearings, metal-polymer bearings and rod end bearings; thrust and specialty ball bearings; and housed bearings. The Engineered Bearings portfolio features Timken® and GGB® brands and serves customers across global industries, including wind energy, agriculture, construction, food and beverage, metals and mining, automotive and truck, aerospace, rail and more.
•
Timken’s Industrial Motion segment includes a diverse and growing portfolio of engineered products, including industrial drives, automatic lubrication systems, linear motion products and systems, chains, belts, couplings and industrial clutches and brakes that keep systems running efficiently. Industrial Motion also includes industrial drivetrain services, which return equipment to like-new condition. The Industrial Motion portfolio features many strong brands: Philadelphia Gear®, Cone Drive®, Spinea®, Rollon®, Nadella®, Groeneveld®, BEKA®, Diamond®, Drives®, Timken® Belts, Lovejoy® and PT Tech®. Industrial Motion products are used across a broad range of industries, including solar energy, automation, construction, agriculture and turf, passenger rail, marine, aerospace, packaging and logistics, medical and more.
Timken creates value by understanding customer needs and applying its know-how to serve a broad range of customers in attractive markets and industries across the globe. The Company’s business strengths include its product technology, end-market diversity, geographic reach and aftermarket mix. Timken collaborates with OEMs to improve equipment efficiency with its engineered products and captures subsequent equipment replacement cycles by selling largely through independent channels in the aftermarket. Timken focuses its international efforts and footprint in regions of the world where strong macroeconomic factors such as urbanization, infrastructure development and sustainability create demand for its products and services.
25
The Company's strategy has three primary elements:
Profitable Growth.
The Company intends to expand into new and existing markets by leveraging its collective knowledge of metallurgy, friction management and industrial motion to create value for Timken customers. Using a highly collaborative technical selling approach, the Company places particular emphasis on creating unique solutions for challenging and/or demanding applications. The Company intends to grow in attractive market sectors around the world, emphasizing those spaces that are highly fragmented, demand high service and value the reliability and efficiency offered by Timken products. The Company also targets applications that offer significant aftermarket demand, thereby providing product and services revenue throughout the equipment’s lifetime.
Operational Excellence.
Timken operates with a relentless drive for exceptional results and a passion for superior execution. The Company embraces a continuous improvement culture that is charged with increasing efficiency, lowering costs, eliminating waste, encouraging organizational agility and building greater brand equity to fuel growth. This requires the Company’s ongoing commitment to attract, retain and develop the best talent across the world.
Capital Deployment to Drive Shareholder Value.
The Company is intently focused on providing the highest returns for shareholders through its capital allocation framework, which includes: (1) investing in the core business through capital expenditures, research and development and initiatives to drive profitable organic growth; (2) pursuing strategic acquisitions to broaden its portfolio and capabilities across diverse markets, with a focus on bearings, adjacent industrial motion products and related services; (3) returning capital to shareholders through dividends and share repurchases; and (4) maintaining a strong balance sheet and sufficient liquidity. As part of this framework, the Company may also restructure, reposition or divest underperforming product lines or assets.
Overview:
|
Three Months Ended
March 31, |
||||||||||||||
| 2023 | 2022 | $ Change | % Change | |||||||||||
| Net sales | $ | 1,262.8 | $ | 1,124.6 | $ | 138.2 | 12.3 | % | ||||||
| Net income | 125.7 | 121.9 | 3.8 | 3.1 | % | |||||||||
| Net income attributable to noncontrolling interest | 3.4 | 3.7 | (0.3) | (8.1) | % | |||||||||
| Net income attributable to The Timken Company | $ | 122.3 | $ | 118.2 | $ | 4.1 | 3.5 | % | ||||||
| Diluted earnings per share | $ | 1.67 | $ | 1.56 | $ | 0.11 | 7.1 | % | ||||||
| Average number of shares – diluted | 73,360,854 | 75,545,665 | — | (2.9) | % | |||||||||
The increase in net sales for the three months ended March 31, 2023 compared with the three months ended March 31, 2022 was
driven by strong organic growth in both the Engineered Bearings and Industrial Motion segments and the favorable impact of acquisitions (net of divestitures), partially offset by the unfavorable impact of foreign currency exchange rate changes. The increase in net income for the three months ended March 31, 2023 compared with the three months ended March 31, 2022 was primarily due to the favorable price/mix and the impact of higher volume, partially offset by higher operating costs and higher impairment and restructuring charges.
Outlook:
The Company expects 2023 full-year revenue to be up between 8% and 11% compared to 2022, driven by organic growth and the benefit of acquisitions (net of divestitures). The Company's earnings are expected to be up in 2023 compared with 2022, due to the favorable impact of price/mix and higher sales volume, as well as lower material and logistics costs, partially offset by higher operating costs, higher impairment and restructuring charges, the unfavorable impact of foreign currency exchange rate changes and higher interest expense.
The Company expects to generate a higher amount of cash from operating activities in 2023 compared to 2022, primarily driven by higher earnings and improved working capital performance. The Company expects higher capital expenditures in 2023 compared to 2022, but relatively in line with 2022 spending as a percentage of sales (4.0%).
26
THE STATEMENT OF INCOME
Operating Income:
|
Three Months Ended
March 31, |
||||||||||||||
| 2023 | 2022 | $ Change | Change | |||||||||||
| Net sales | $ | 1,262.8 | $ | 1,124.6 | $ | 138.2 | 12.3% | |||||||
| Cost of products sold | 846.0 | 786.3 | 59.7 | 7.6% | ||||||||||
| Selling, general and administrative expenses | 186.8 | 154.1 | 32.7 | 21.2% | ||||||||||
| Amortization of intangible assets | 13.5 | 10.9 | 2.6 | 23.9% | ||||||||||
| Impairment and restructuring charges | 28.9 | 1.0 | 27.9 | NM | ||||||||||
| Operating income | $ | 187.6 | $ | 172.3 | 15.3 | 8.9% | ||||||||
| Operating income % to net sales | 14.9 | % | 15.3 | % | (40) | bps | ||||||||
Net sales increased for the three months ended March 31, 2023 compared with the three months ended March 31, 2022. The increase was driven by strong organic growth of $123 million and the benefit of acquisitions (net of divestitures) of $45 million, partially offset by the unfavorable impact of foreign currency exchange rate changes of $30 million. The higher organic revenue was driven by higher demand and positive pricing in both the Engineered Bearings and Industrial Motion segments.
Operating income increased for the three months ended March 31, 2023 compared with the three months ended March 31, 2022, due to the favorable net impact of higher sales volume (including pricing), less cost of products sold, partially offset by higher selling, general and administrative ("SG&A") expenses, higher impairment and restructuring charges and increased amortization expense.
•
Cost of products sold increased for the three months ended March 31, 2023 compared with the three months ended March 31, 2022, due to higher manufacturing costs, net of favorable mix impact, of $57 million, and the incremental cost of goods sold from acquisitions (net of divestitures) of $34 million, partially offset by the impact of foreign currency exchange rate changes of $16 million and lower material and logistics costs of $14 million. The higher manufacturing costs reflect continued labor and input cost inflation, as well as the impact of reduced inventory build in the current quarter compared to a year ago.
•
SG&A expenses increased for the three months ended March 31, 2023 compared with the three months ended March 31, 2022. The increase for the three months ended March 31, 2023, as compared to the year-ago period was primarily due to higher compensation costs (including incentive-based compensation) and increased spending to support the higher sales and business activity levels.
•
Amortization of intangible assets increased for the three months ended March 31, 2023 compared with the three months ended March 31, 2022, primarily due to the addition of intangible assets from the GGB acquisition, which was completed in the fourth quarter of 2022.
•
Impairment and restructuring charges were higher for the three months ended March 31, 2023 compared with the three months ended March 31, 2022 primarily due to the impairment of goodwill. During the first quarter of 2023, the Company reviewed goodwill for impairment for its reporting units due to the change in reporting segments that went into effect January 1, 2023. As a result of this analysis the Company determined that one of the new reporting units within the Industrial Motion segment could not support the carrying value of its goodwill, and subsequently recorded a pretax impairment loss of $28.3 million in the first quarter of 2023.
27
Interest Income and Expense:
|
Three Months Ended
March 31, |
||||||||||||||
| 2023 | 2022 | $ Change | % Change | |||||||||||
| Interest expense | $ | (24.1) | $ | (14.3) | $ | (9.8) | 68.5 | % | ||||||
| Interest income | 1.5 | 0.6 | $ | 0.9 | 150.0 | % | ||||||||
The increase in interest expense for the three months ended March 31, 2023 compared with the three months ended March 31, 2022 was due to increased debt levels and higher average interest rates.
Other Income (Expense):
|
Three Months Ended
March 31, |
||||||||||||||
| 2023 | 2022 | $ Change | % Change | |||||||||||
| Non-service pension and other postretirement income | $ | 0.1 | $ | 1.3 | $ | (1.2) | (92.3) | % | ||||||
| Other income, net | 3.1 | 0.2 | 2.9 | NM | ||||||||||
| Total other income | $ | 3.2 | $ | 1.5 | $ | 1.7 | 113.3 | % | ||||||
Other income, net increased for the three months ended March 31, 2023 compared with the three months ended March 31, 2022, due to gains on divestitures of $4.0 million primarily related to the sale of SE Setco
, a 50% owned joint venture, partially offset foreign currency losses of $0.2 million, net of derivative activity, during the three months ended March 31, 2023, compared to foreign currency gains of $0.5 million, net of derivative activity, during the three months ended March 31, 2022.
Income Tax Expense:
|
Three Months Ended
March 31, |
||||||||||||||
| 2023 | 2022 | $ Change | Change | |||||||||||
| Provision for income taxes | $ | 42.5 | $ | 38.2 | $ | 4.3 | 11.3 | % | ||||||
| Effective tax rate | 25.3 | % | 23.9 | % | 140 | bps | ||||||||
Income tax expense increased $4.3 million for the three months ended March 31, 2023 compared with the three months ended March 31, 2022 primarily due to an increase in the mix of earnings in international jurisdictions with relatively higher tax rates.
Refer to
Note 6 - Income Taxes
for more information on the computation of the income tax expense in interim periods.
28
BUSINESS SEGMENTS
The Company
'
s reportable segments are product-based business groups that serve customers in diverse industrial markets. The primary measurement used by management to measure the financial performance of each segment is EBITDA. Refer to
Note 4 - Segment Information
in the Notes to the Consolidated Financial Statements for the reconciliation of EBITDA by segment to consolidated income before income taxes.
The presentation of segment results below includes a reconciliation of the changes in net sales for each segment reported in accordance with U.S. GAAP to net sales adjusted to remove the effects of acquisitions and divestitures completed in 2023 and 2022 and foreign currency exchange rate changes. The effects of acquisitions, divestitures and foreign currency exchange rate changes on net sales are removed to allow investors and the Company to meaningfully evaluate the percentage change in net sales on a comparable basis from period to period.
The following item represents the Company's acquisitions and divestitures completed in 2023 and 2022:
•
The Company acquired ARB during the first quarter of 2023. Results for ARB are reported in the Engineered Bearings segment.
•
The Company acquired GGB during the fourth quarter of 2022. Results for GGB are reported in the Engineered Bearings segment.
•
The Company completed the sale of Timken Aerospace Drive Systems ("ADS") during the fourth quarter of 2022. Results for ADS were reported in the Industrial Motion segment.
•
The Company completed the sale of Timken-Rus Service Company ooo ("Timken Russia") during the third quarter of 2022. Results for Timken Russia were reported in the Engineered Bearings segment.
•
The Company acquired Spinea during the second quarter of 2022. Results for Spinea are reported in the Industrial Motion segment.
Engineered Bearings Segment:
|
Three Months Ended
March 31, |
||||||||||||||
| 2023 | 2022 | $ Change | Change | |||||||||||
| Net sales | $ | 900.7 | $ | 772.4 | $ | 128.3 | 16.6% | |||||||
| EBITDA | $ | 205.0 | $ | 168.3 | $ | 36.7 | 21.8% | |||||||
| EBITDA margin | 22.8 | % | 21.8 | % | 100 | bps | ||||||||
|
Three Months Ended
March 31, |
||||||||||||||
| 2023 | 2022 | $ Change | % Change | |||||||||||
| Net sales | $ | 900.7 | $ | 772.4 | $ | 128.3 | 16.6 | % | ||||||
| Less: Acquisitions | 55.7 | 55.7 | NM | |||||||||||
| Divestitures | (3.5) | (3.5) | NM | |||||||||||
| Currency | (22.1) | (22.1) | NM | |||||||||||
|
Net sales, excluding the impacts of acquisitions, divestitures
and currency |
$ | 811.4 | $ | 772.4 | $ | 39.0 | 5.0 | % | ||||||
The Engineered Bearings segment's net sales, excluding the effects of acquisitions, divestitures and foreign currency exchange rate changes, increased $39.0 million or 5.0% in the three months ended March 31, 2023 compared with the three months ended March 31, 2022. The increase
reflects organic growth (including pricing) across most sectors, led by renewable energy, distribution, rail and heavy industries. EBITDA increased by $36.7 million or 21.8% for the three months ended March 31, 2023 compared with the three months ended March 31, 2022, primarily due to favorable price/mix, the impact of higher sales volume, lower material and logistics costs and the benefit of acquisitions, partially offset by higher manufacturing costs and SG&A expenses, and the unfavorable impact of foreign currency exchange rate changes.
29
Industrial Motion Segment:
|
Three Months Ended
March 31, |
||||||||||||||
| 2023 | 2022 | $ Change | Change | |||||||||||
| Net sales | $ | 362.1 | $ | 352.2 | $ | 9.9 | 2.8% | |||||||
| EBITDA | $ | 48.2 | $ | 62.4 | $ | (14.2) | (22.8%) | |||||||
| EBITDA margin | 13.3 | % | 17.7 | % | (440) | bps | ||||||||
|
Three Months Ended
March 31, |
||||||||||||||
| 2023 | 2022 | $ Change | % Change | |||||||||||
| Net sales | $ | 362.1 | $ | 352.2 | $ | 9.9 | 2.8 | % | ||||||
| Less: Acquisitions | 5.3 | 5.3 | NM | |||||||||||
| Divestitures | (12.8) | (12.8) | NM | |||||||||||
| Currency | (7.5) | (7.5) | NM | |||||||||||
|
Net sales, excluding the impact of acquisitions,
divestitures and currency |
$ | 377.1 | $ | 352.2 | $ | 24.9 | 7.1 | % | ||||||
The Industrial Motion segment's net sales, excluding the effects of acquisitions, divestitures and foreign currency exchange rate changes, increased $24.9 million or 7.1% in the three months ended March 31, 2023 compared with the three months ended March 31, 2022
. The increase reflects organic growth (including pricing) across the portfolio, with the automatic lubrication systems platform posting the strongest growth. EBITDA decreased $14.2 million or 22.8% for the three months ended March 31, 2023 compared with the three months ended March 31, 2022 primarily due to higher impairment and restructuring charges, as well as higher manufacturing costs and SG&A expenses, partially offset by favorable price/mix and the impact of higher sales volume. The higher impairment and restructuring charges were primarily related to the impairment of goodwill for one of the segment's reporting units.
Unallocated Corporate
|
Three Months Ended
March 31, |
||||||||||||||
| 2023 | 2022 | $ Change | Change | |||||||||||
| Unallocated corporate expense | $ | (17.7) | $ | (12.9) | $ | (4.8) | 37.2 | % | ||||||
| Unallocated corporate expense % to net sales | (1.4) | % | (1.1) | % | (30) | bps | ||||||||
The increase in unallocated corporate expense for the
three
months ended March 31, 2023 compared with the
three
months ended March 31, 2022 was primarily due to higher compensation expense and other spending to support increased business activity levels.
30
CASH FLOW
|
Three Months Ended
March 31, |
|||||||||||
| 2023 | 2022 | $ Change | |||||||||
| Net cash provided by (used in) operating activities | $ | 78.6 | $ | (1.2) | $ | 79.8 | |||||
| Net cash used in investing activities | (64.5) | (35.0) | (29.5) | ||||||||
| Net cash (used in) provided by financing activities | (17.5) | 204.7 | (222.2) | ||||||||
| Effect of exchange rate changes on cash | 1.8 | (1.2) | 3.0 | ||||||||
| (Decrease) Increase in cash and cash equivalents and restricted cash | $ | (1.6) | $ | 167.3 | $ | (168.9) | |||||
Op
erating Activities:
The increase in net cash provided by operating activities for the first
three
months of 2023 compared with the first
three
months of 2022 was primarily due to a decrease in cash used for working capital items of $74.6 million.
Refer to the tables below for additional detail of the
impact of each line item on net cash provided by operating activities.
The following table displays the impact of working capital items on cash during the
three
months of 2023 and 2022, respectively:
|
Three Months Ended
March 31, |
|||||||||||
| 2023 | 2022 | $ Change | |||||||||
| Cash (used in) provided by: | |||||||||||
| Accounts receivable | $ | (50.3) | $ | (118.2) | $ | 67.9 | |||||
| Unbilled receivables | (11.1) | 16.1 | (27.2) | ||||||||
| Inventories | 6.1 | (70.2) | 76.3 | ||||||||
| Trade accounts payable | (9.4) | 7.7 | (17.1) | ||||||||
| Other accrued expenses | (44.8) | (19.5) | (25.3) | ||||||||
| Cash used in working capital items | $ | (109.5) | $ | (184.1) | $ | 74.6 | |||||
The following table displays the impact of income taxes on cash during the first
three
months of 2023 and 2022, respectively:
|
Three Months Ended
March 31, |
|||||||||||
| 2023 | 2022 | $ Change | |||||||||
| Accrued income tax expense | $ | 42.5 | $ | 38.2 | $ | 4.3 | |||||
| Income tax payments | (54.8) | (25.3) | (29.5) | ||||||||
| Other items | 0.1 | (4.8) | 4.9 | ||||||||
| Change in income taxes | $ | (12.2) | $ | 8.1 | $ | (20.3) | |||||
Investing Activities:
The increase in net cash used in investing activities for the first
three
months of 2023 compared with the first
three
months of 2022 was primarily due to an increase in cash used for acquisitions of $29.2 million.
Financing Activities:
The change in net cash used in financing activities for the first
three
months of 2023 compared with the first
three
months of 2022 was primarily due to an increase in net borrowings of $269.3 million, partially offset by an decrease in the purchases of treasury shares of $46.0 million.
31
LIQUIDITY AND CAPITAL RESOURCES
Reconciliation of total debt to net debt and the ratio of net debt to capital:
Net Debt:
|
March 31,
2023 |
December 31,
2022 |
|||||||
| Short-term debt, including current portion of long-term debt | $ | 48.6 | $ | 49.0 | ||||
| Long-term debt | 1,978.8 | 1,914.2 | ||||||
| Total debt | $ | 2,027.4 | $ | 1,963.2 | ||||
| Less: Cash and cash equivalents | 330.5 | 331.6 | ||||||
| Net debt | $ | 1,696.9 | $ | 1,631.6 | ||||
Ratio of Net Debt to Capital:
|
March 31,
2023 |
December 31,
2022 |
|||||||
| Net debt | $ | 1,696.9 | $ | 1,631.6 | ||||
| Total equity | 2,436.3 | 2,352.9 | ||||||
| Net debt plus total equity (capital) | $ | 4,133.2 | $ | 3,984.5 | ||||
| Ratio of net debt to capital | 41.1 | % | 40.9 | % | ||||
The Company presents net debt because it believes net debt is more representative of the Company's financial position than total debt due to the amount of cash and cash equivalents held by the Company and the ability to utilize such cash and cash equivalents to reduce debt if needed.
At March 31, 2023, the Company had strong liquidity with $330.5 million of cash and cash equivalents on the Consolidated Balance Sheet, as well as $686.4 million available under committed credit lines. Of the $330.5 million of cash and cash equivalents, $327.9 million resided in jurisdictions outside the United States. Repatriation of non-U.S. cash could be subject to taxes and some portion may be subject to governmental restrictions. Part of the Company's strategy is to
grow in attractive market sectors, many of which are outside the United States. This strategy includes making investments in facilities, equipment and potential new acquisitions. The Company plans to fund these investments, as well as meet working capital requirements, with cash and cash equivalents and unused lines of credit within the geographic location of these investments where feasible.
On December 5, 2022, the Company entered into the Credit Agreement, which is comprised of the $750.0 million Senior Credit Facility and the $400.0 million 2027 Term Loan that each mature on December 5, 2027. The Credit Agreement amended and restated the Company's previous revolving credit agreement that was set to mature on June 25, 2024, and replaced the $350.0 million 2023 Term Loan. The Credit Agreement also replaced interest rates based on LIBOR with interest rates based on SOFR. At March 31, 2023, the Company had $63.6 million of outstanding borrowings under the Senior Credit Facility, which reduced the availability under this facility to $686.4 million. The Credit Agreement has two financial covenants: a consolidated leverage ratio and a consolidated interest coverage ratio.
The maximum consolidated
leverage ratio permitted under the Senior Credit Facility is 3.5 to 1.0. As of March 31, 2023, the Company's consolidated leverage ratio was 1.84 to 1.0. The minimum consolidated interest coverage ratio permitted under the Senior Credit Facility is 3.0 to 1.0. As of March 31, 2023, the Company's consolidated interest coverage ratio was 11.33 to 1.0.
The interest rate under the Senior Credit Facility is variable with a spread based on the Company's debt rating. The average rate on outstanding U.S. dollar borrowings was 5.72% and the average rate on outstanding Euro borrowings was 3.46% as of March 31, 2023. In addition, the Company pays a facility fee based on the applicable rate, which is variable with a spread based on the Company's debt rating, multiplied by the aggregate commitments of all of the lenders under the Senior Credit Facility. As of March 31, 2023, the Company carried investment-grade credit ratings with both Moody's (Baa2) and S&P Global (BBB-).
32
The Company has a $100 million Accounts Receivable Facility, which matures on November 30, 2024. The Accounts Receivable Facility is subject to certain borrowing base limitations and is secured by certain domestic trade accounts receivable of the Company. As of March 31, 2023, the Company had $100 million outstanding borrowings under the Accounts Receivable Facility and no borrowing base limitations. There was no availability under the Accounts Receivable Facility as of March 31, 2023.
Other sources of liquidity include uncommitted short-term lines of credit for certain of the Company's foreign subsidiaries, which provide for borrowings of up to $237.4 million. At March 31, 2023, the Company had borrowings outstanding of $38.7 million and bank guarantees of $3.7 million, which reduced the aggregate availability under these facilities to $195.0 million.
On March 28, 2022, the Company issued the 2032 Notes in the aggregate principal amount of $350 million with an interest rate of 4.125%, maturing on April 1, 2032. Proceeds from the 2032 Notes were used for general corporate purposes, which included repayment of borrowings under the Senior Credit Facility and the Accounts Receivable Facility outstanding at the time of issuance.
At March 31, 2023, the Company was in full compliance with all applicable covenants on its outstanding debt.
The Company expects to generate higher amount of cash from operating activities in 2023 compared to 2022, driven by higher earnings and improved working capital performance. The Company expects higher capital expenditures in 2023 compared to 2022, but relatively in line with 2022 spending as a percentage of sales (4.0%).
Financing Obligations and Other Commitments:
During the first three months of 2023, the Company made cash contributions and payments of $4.4 million to its global defined benefit pension plans and $0.4 million to its other postretirement benefit plans. The Company expects to make contributions to its global defined benefit plans of approximately $25 million in 2023. The Company expects to make payments of approximately $4 million to its other postretirement benefit plans in 2023. Excluding mark-to-market charges, the Company expects higher pension and other postretirement benefits expense in 2023 compared to 2022 primarily due to lower expected returns on pension plan assets.
The Company does not have any off-balance sheet arrangements with unconsolidated entities or other persons.
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
The Company's financial statements are prepared in accordance with U.S. GAAP. The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the periods presented. The Company reviews its critical accounting policies throughout the year. The Company has concluded that there have been no significant changes to its critical accounting policies or estimates, as described in its Annual Report on Form 10-K for the year ended December 31, 2022, during the three months ended March 31, 2023.
33
OTHER MATTERS
Foreign Currency:
Assets and liabilities of subsidiaries are translated at the rate of exchange in effect on the balance sheet date; income and expenses are translated at the average rates of exchange prevailing during the reporting period. Related translation adjustments are reflected as a separate component of accumulated other comprehensive loss. Foreign currency gains and losses resulting from transactions, and the related hedging activity, are included in the Consolidated Statements of Income.
For the three months ended March 31, 2023, the Company recorded positive foreign currency translation adjustments of $27.4 million that increased shareholders' equity, compared with negative foreign currency translation adjustments of $20.0 million that decreased shareholders' equity for the three months ended March 31, 2022. The foreign currency translation adjustments for the three months ended March 31, 2023 were favorably impacted by the weakening of the U.S. dollar relative to other foreign currencies, including the Euro, Mexican Peso and Chinese Yuan.
Foreign currency exchange gains and losses, net of hedging activity, resulting from transactions included in the Company's operating results for the three months ended March 31, 2023 totaled $3.0 million of net losses, compared with $2.2 million of net gains during the three months ended March 31, 2022.
Russia Operations:
The Company had two subsidiaries in Russia prior to Russia's invasion of Ukraine in February 2022, including Timken Russia, which was 100% owned by Timken and a 51%-owned joint venture to serve the Russian rail market ("Rail JV"). As a result of Russia's invasion of Ukraine (and associated sanctions), the Company suspended operations and recorded property, plant and equipment impairment charges of $9.0 million and inventory write-downs of $4.1 million during the year ended December 31, 2022. During the third quarter of 2022, the Company sold its Timken Russia business resulting in a loss of $2.7 million on the sale. During the first quarter of 2023, the Company recorded additional inventory write-downs of $0.4 million. After giving effect to these impairments and write-downs, as well as the sale of Timken Russia, as of March 31, 2023, the Company has net assets (net of noncontrolling interest of $5.2 million), totaling $7.2 million on its Consolidated Balance Sheet related to its Rail JV. Net assets include $7.9 million of cash and cash equivalents that the Company has classified as restricted as the Company is presently unable to repatriate these funds to one of its subsidiaries outside of Russia. The Company will continue to monitor the events in Russia and Ukraine and may record additional asset impairments or write-offs in the future.
34
NON-GAAP MEASURES
Supplemental Non-GAAP Measures:
In addition to results reported in accordance with U.S. GAAP, the Company provides information on non-GAAP financial measures. These non-GAAP financial measures include adjusted net income, adjusted earnings per share, adjusted EBITDA and adjusted EBITDA margins, segment adjusted EBITDA and segment adjusted EBITDA margins, ratio of net debt to adjusted EBITDA (for the trailing 12 months), net debt, ratio of net debt to capital and free cash flow. This information is intended to supplement GAAP financial measures and is not intended to replace GAAP financial measures. Net debt and the ratio of net debt to capital is disclosed in the "Liquidity and Capital Resources" section of Management's Discussion and Analysis of Financial Condition and Results of Operations.
Adjusted Net Income and Adjusted EBITDA:
Adjusted net income and adjusted earnings per share represent net income attributable to The Timken Company and diluted earnings per share, respectively, adjusted for intangible amortization, impairment, restructuring and reorganization charges, acquisition costs, including transaction costs and the amortization of the inventory step-up, property losses and recoveries, actuarial gains and losses associated with the remeasurement of the Company's defined benefit pension and other postretirement benefit plans, gains and losses on the sale of real estate, gains and losses on divestitures, the income tax impact of these adjustments, as well as other discrete income tax items, and other items from time to time that are not part of the Company's core operations. Management believes adjusted net income and adjusted earnings per share are useful to investors as they are representative of the Company's core operations and are used in the management of the business.
Adjusted EBITDA represents earnings before interest, taxes, depreciation and amortization, adjusted for items that are not part of the Company's core operations. These items include intangible amortization, impairment, restructuring and reorganization charges, acquisition costs, including transaction costs and the amortization of the inventory step-up, property losses and recoveries, actuarial gains and losses associated with the remeasurement of the Company's defined benefit pension and other postretirement benefit plans, gains and losses on the sale of real estate, gains and losses on divestitures, and other items from time to time that are not part of the Company's core operations. Management believes adjusted EBITDA is useful to investors as it is representative of the Company's core operations and is used in the management of the business, including decisions concerning the allocation of resources and assessment of performance.
35
Reconciliation of net income attributable to The Timken Company to adjusted net income, adjusted EBITDA and adjusted EBITDA Margin:
|
Three Months Ended
March 31, |
||||||||
| 2023 | 2022 | |||||||
| Net Sales | $ | 1,262.8 | $ | 1,124.6 | ||||
| Net Income Attributable to The Timken Company | 122.3 | 118.2 | ||||||
| Net Income Attributable to The Timken Company as a Percentage of Sales | 9.7 | % | 10.5 | % | ||||
| Adjustments: | ||||||||
| Acquisition intangible amortization | 13.5 | 10.9 | ||||||
|
Impairment, restructuring and reorganization charges
(1)
|
30.0 | 1.6 | ||||||
|
Corporate pension and other postretirement benefit related (income) expense
(2)
|
(0.9) | 2.6 | ||||||
|
Russia-related charges
(3)
|
0.3 | 4.6 | ||||||
|
Acquisition-related charges
(4)
|
4.7 | 1.1 | ||||||
|
Gain on divestitures and sale of real estate
(5)
|
(4.8) | — | ||||||
| Noncontrolling interest of above adjustments | (0.2) | (1.3) | ||||||
|
Provision for income taxes
(6)
|
(11.4) | (8.0) | ||||||
| Adjusted Net Income | $ | 153.5 | $ | 129.7 | ||||
| Net income attributable to noncontrolling interest | 3.4 | 3.7 | ||||||
| Provision for income taxes (as reported) | 42.5 | 38.2 | ||||||
| Interest expense | 24.1 | 14.3 | ||||||
| Interest income | (1.5) | (0.6) | ||||||
|
Depreciation and amortization expense
(7)
|
45.4 | 41.4 | ||||||
| Less: Acquisition intangible amortization | 13.5 | 10.9 | ||||||
| Less: Noncontrolling interest | (0.2) | (1.3) | ||||||
|
Less: Provision for income taxes
(6)
|
(11.4) | (8.0) | ||||||
| Adjusted EBITDA | $ | 265.5 | $ | 225.1 | ||||
| Adjusted EBITDA Margin (% of net sales) | 21.0 | % | 20.0 | % | ||||
Diluted earnings and adjusted earnings per share in the table below are based on net income attributable to The Timken Company and adjusted net income, respectively, in the table above.
|
Three Months Ended
March 31, |
||||||||
| 2023 | 2022 | |||||||
| Diluted earnings per share (EPS) | $ | 1.67 | $ | 1.56 | ||||
| Adjusted EPS | $ | 2.09 | $ | 1.72 | ||||
| Diluted Shares | 73,360,854 | 75,545,665 | ||||||
36
Reconciliation of segment EBITDA to segment adjusted EBITDA and segment adjusted EBITDA margin:
| Three Months Ended March 31, 2023 | ||||||||||||||
| Engineered Bearings | Industrial Motion | Unallocated Corporate | Total | |||||||||||
| Net Sales | $ | 900.7 | $ | 362.1 | $ | — | $ | 1,262.8 | ||||||
| EBITDA | 205.0 | 48.2 | (16.8) | 236.4 | ||||||||||
|
Impairment, restructuring and reorganization
charges
(1)
|
1.1 | 28.7 | — | 29.8 | ||||||||||
|
Corporate pension and other postretirement benefit
related income
(2)
|
— | — | (0.9) | (0.9) | ||||||||||
|
Russia-related charges
(3)
|
0.3 | — | 0.3 | |||||||||||
|
Acquisition-related charges
(4)
|
2.2 | — | 2.5 | 4.7 | ||||||||||
|
Gain on divestitures and sale of real estate
(5)
|
(4.8) | — | — | (4.8) | ||||||||||
| Adjusted EBITDA | $ | 203.8 | $ | 76.9 | $ | (15.2) | $ | 265.5 | ||||||
| Adjusted EBITDA Margin (% of net sales) | 22.6 | % | 21.2 | % | NM | 21.0 | % | |||||||
| Three Months Ended March 31, 2022 | ||||||||||||||
| Engineered Bearings | Industrial Motion | Unallocated Corporate | Total | |||||||||||
| Net Sales | $ | 772.4 | $ | 352.2 | $ | — | $ | 1,124.6 | ||||||
| EBITDA | 168.3 | 62.4 | (15.5) | 215.2 | ||||||||||
|
Impairment, restructuring and reorganization
charges
(1)
|
1.0 | 0.6 | — | 1.6 | ||||||||||
|
Corporate pension and other postretirement
benefit related expense
(2)
|
— | — | 2.6 | 2.6 | ||||||||||
|
Russia-related charges
(3)
|
4.6 | — | — | 4.6 | ||||||||||
|
Acquisition-related charges
(4)
|
— | 0.4 | 0.7 | 1.1 | ||||||||||
| Adjusted EBITDA | $ | 173.9 | $ | 63.4 | $ | (12.2) | $ | 225.1 | ||||||
| Adjusted EBITDA Margin (% of net sales) | 22.5 | % | 18.0 | % | NM | 20.0 | % | |||||||
(1)
Impairment, restructuring and reorganization charges (including items recorded in cost of products sold) relate to: (i) plant closures; (ii) the rationalization of certain plants; (iii) severance related to cost reduction initiatives; and (iv) impairment of assets. Impairment, restructuring and reorganization charges for 2023 included $28.3 million related to the impairment of goodwill. The Company re-assesses its operating footprint and cost structure periodically, and makes adjustments as needed that result in restructuring charges. However, management believes these actions are not representative of the Company’s core operations
.
(2)
Corporate pension and other postretirement benefit related (income) expense represents actuarial (gains) and losses that resulted from the remeasurement of plan assets and obligations as a result of changes in assumptions or experience. The Company recognizes actuarial (gains) and losses in connection with the annual remeasurement in the fourth quarter, or if specific events trigger a remeasurement. Refer to
Note 16 - Retirement Benefit Plans
and
Note 17 - Other Postretirement Benefit Plans
for additional discussion.
(3)
Russia-related charges include impairments and allowances recorded against certain property, plant and equipment, inventory and trade receivables to reflect the current impact of Russia's invasion of Ukraine (and associated sanctions) on the Company's operations. In addition to impairments and allowances recorded, the Company recorded a loss on the divestiture of its Timken Russia business during the fourth quarter of 2022. Refer to Russia Operations on page
34
above for additional information.
(4)
Acquisition-related charges represent deal-related expenses associated with completed transactions and any resulting inventory step-up impact.
(5)
Represents the net gain resulting from divestitures and the sale of real estate.
(6)
Provision for income taxes includes the net tax impact on pre-tax adjustments (listed above), the impact of discrete tax items recorded during the respective periods as well as other adjustments to reflect the use of one overall effective tax rate on adjusted pre-tax income in interim periods.
(7)
Depreciation and amortization shown excludes depreciation recognized in reorganization charges, if any.
37
Free Cash Flow:
Free cash flow represents net cash provided by (used in) operating activities less capital expenditures. Management believes free cash flow is useful to investors because it is a meaningful indicator of cash generated from operating activities available for the execution of its business strategy.
Reconciliation of net cash provided by operating activities to free cash flow:
|
Three Months Ended
March 31, |
||||||||
| 2023 | 2022 | |||||||
| Net cash provided by (used in) operating activities | $ | 78.6 | $ | (1.2) | ||||
| Capital expenditures | (41.7) | (34.3) | ||||||
| Free cash flow | $ | 36.9 | $ | (35.5) | ||||
38
Ratio of Net Debt to Adjusted EBITDA:
The ratio of net debt to adjusted EBITDA for the trailing twelve months represents total debt less cash and cash equivalents divided by adjusted EBITDA for the trailing twelve months. T
he Company presents net debt to adjusted EBITDA because it believes it is more representative of the Company's financial position as it is reflective of the Company's ability to cover its net debt obligations with results from its core operations. Net income for the trailing twelve months ended March 31, 2023 and December 31, 2022 was $420.8 million and $417.0 million, respectively.
Net debt to adjusted EBITDA for the trailing twelve months was 1.9 at March 31, 2023 and December 31, 2022.
Reconciliation of Net income to Adjusted EBITDA for the trailing twelve months:
| Twelve Months Ended | ||||||||
|
March 31,
2023 |
December 31,
2022 |
|||||||
| Net income | $ | 420.8 | $ | 417.0 | ||||
| Provision for income taxes | 138.2 | 133.9 | ||||||
| Interest expense | 84.4 | 74.6 | ||||||
| Interest income | (4.7) | (3.8) | ||||||
| Depreciation and amortization | 168.2 | 164.0 | ||||||
| Consolidated EBITDA | 806.9 | 785.7 | ||||||
| Adjustments: | ||||||||
|
Impairment, restructuring and reorganization charges
(1)
|
$ | 67.7 | $ | 39.5 | ||||
|
Corporate pension and other postretirement benefit related (income) expense
(2)
|
(0.6) | 2.9 | ||||||
|
Acquisition-related charges
(3)
|
18.4 | 14.8 | ||||||
|
Gain on divestitures and sale of real estate
(4)
|
(7.7) | (2.9) | ||||||
|
Russia-related charges
(5)
|
11.3 | 15.6 | ||||||
| Tax indemnification and related items | 0.3 | 0.3 | ||||||
| Total adjustments | 89.4 | 70.2 | ||||||
| Adjusted EBITDA | $ | 896.3 | $ | 855.9 | ||||
| Net Debt | $ | 1,696.9 | $ | 1,631.6 | ||||
| Ratio of Net Debt to Adjusted EBITDA | 1.9 | 1.9 | ||||||
(1)
Impairment, restructuring and reorganization charges (including items recorded in cost of products sold) relate to: (i) plant closures; (ii) the rationalization of certain plants; (iii) severance related to cost reduction initiatives; and (iv) impairment of assets. Impairment, restructuring and reorganization charges for the twelve months ended December 31, 2022 and March 31, 2023 included $29.3 million related to the sale of ADS. In addition, impairment, restructuring and reorganization charges for the twelve months ended March 31, 2023 included $28.3 million related to the impairment of goodwill. The Company re-assesses its operating footprint and cost structure periodically, and makes adjustments as needed that result in restructuring charges. However, management believes these actions are not representative of the Company’s core operations.
(2)
Corporate pension and other postretirement benefit related (income) expense represents actuarial (gains) and losses that resulted from the remeasurement of plan assets and obligations as a result of changes in assumptions or experience. The Company recognizes actuarial (gains) and losses in connection with the annual remeasurement in the fourth quarter, or if specific events trigger a remeasurement.
(3)
Acquisition-related charges represent deal-related expenses associated with completed transactions and any resulting inventory step-up impact.
(4)
Represents the net gain resulting from divestitures and the sale of real estate.
(5)
Russia-related charges include allowances and impairments recorded against certain trade receivables, inventory and other assets to reflect the current impact of Russia's invasion of Ukraine (and associated sanctions) on the Company's operations. In addition to impairments and allowances recorded, the Company recorded a loss on the divestiture of its Timken Russia business during the fourth quarter of 2022. Refer to Russia Operations on page
34
in Management Discussion and Analysis for additional information.
39
FORWARD-LOOKING STATEMENTS
Certain statements set forth in this Form 10-Q and in the Company's Annual Report on Form 10-K for the year ended December 31, 2022 that are not historical in nature (including the Company's forecasts, beliefs and expectations) are “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995. In particular, Management's Discussion and Analysis contains numerous forward-looking statements. Forward-looking statements generally will be accompanied by words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “forecast,” “outlook,” “intend,” “may,” “possible,” “potential,” “predict,” “project” or other similar words, phrases or expressions. You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this Form 10-Q. The Company cautions readers that actual results may differ materially from those expressed or implied in forward-looking statements made by or on behalf of the Company due to a variety of factors, such as:
•
deterioration in world economic conditions, or in economic conditions in any of the geographic regions in which the Company or its customers or suppliers conduct business, including adverse effects from a global economic slowdown or recession, terrorism, or hostilities. This includes: political risks associated with the potential instability of governments and legal systems in countries in which the Company or its customers or suppliers conduct business, changes in currency valuations and recent world events that have increased the risks posed by international trade disputes, tariffs and sanctions;
•
negative impacts to the Company's business, results of operations, financial position or liquidity, disruption to the Company's supply chains, negative impacts to customer demand or operations, and availability and health of employees, as a result of COVID-19 or other pandemics and associated governmental measures such as restrictions on travel and manufacturing operations;
•
the effects of fluctuations in customer demand on sales, product mix and prices in the industries in which the Company operates. This includes: the ability of the Company to respond to rapid changes in customer demand, disruptions to the Company's supply chain, logistical issues associated with port closures or congestion, delays or increased costs, the effects of customer or supplier bankruptcies or liquidations, the impact of changes in industrial business cycles, the effects of distributor inventory corrections reflecting de-stocking of the supply chain and whether conditions of fair trade continue in the Company's markets;
•
competitive factors, including changes in market penetration, increasing price competition by existing or new foreign and domestic competitors, the introduction of new products or services by existing and new competitors, competition for skilled labor and new technology that may impact the way the Company’s products are produced, sold or distributed;
•
changes in operating costs. This includes: the effect of changes in the Company’s manufacturing processes; changes in costs associated with varying levels of operations and manufacturing capacity; availability and cost of raw materials and energy; disruptions to the Company's supply chain and logistical issues associated with port closures or congestion, delays or increased costs; changes in the expected costs associated with product warranty claims; changes resulting from inventory management and cost reduction initiatives; the effects of unplanned plant shutdowns; the effects of government-imposed restrictions, commercial requirements and Company goals associated with climate change and emissions or other waste reduction initiatives; and changes in the cost of labor and benefits;
•
the impact of inflation on employee expenses, shipping costs, raw material costs, energy and fuel costs and other production costs;
•
the success of the Company’s operating plans, announced programs, initiatives and capital investments; the ability to integrate acquired companies and to address material issues both identified and not uncovered during the Company's due diligence review; and the ability of acquired companies to achieve satisfactory operating results, including results being accretive to earnings, realization of synergies and expected cash flow generation;
•
the Company’s ability to maintain appropriate relations with unions or works councils that represent Company associates in certain locations in order to avoid disruptions of business; the continued attraction, retention and development of management and other key employees, the successful development and execution of succession plans and management of other human capital matters;
•
unanticipated litigation, claims, investigations or assessments. This includes: claims, investigations or problems related to intellectual property, product liability or warranty, foreign export and trade laws, government procurement regulations, competition and anti-bribery laws, climate change, environmental or health and safety issues, data privacy and taxes;
40
•
changes in worldwide financial and capital markets impacting the availability of financing on satisfactory terms, as a result of financial stress affecting the banking system or otherwise, and the rising interest rate environment, which affect the Company’s cost of funds and/or ability to raise capital, as well as customer demand and the ability of customers to obtain financing to purchase the Company’s products or equipment that contain the Company’s products;
•
the Company's ability to satisfy its obligations and comply with covenants under its debt agreements, maintain favorable credit ratings and its ability to renew or refinance borrowings on favorable terms;
•
the impact on the Company's pension obligations and assets due to changes in interest rates, investment performance and other tactics designed to reduce risk; and
•
those items identified under Item 1A. "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2022 or this Form 10-Q.
Additional risks relating to the Company's business, the industries in which the Company operates, or the Company's common shares may be described from time to time in the Company's filings with the Securities and Exchange Commission. All of these risk factors are difficult to predict, are subject to material uncertainties that may affect actual results and may be beyond the Company's control.
Readers are cautioned that it is not possible to predict or identify all of the risks, uncertainties and other factors that may affect future results and that the above list should not be considered to be a complete list. Except as required by the federal securities laws, the Company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.
41
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Refer to information appearing under the caption “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of this Form 10-Q. Furthermore, a discussion of market risk exposures is included in Part II, Item 7A. Quantitative and Qualitative Disclosure about Market Risk, of the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. There have been no material changes in reported market risk since the inclusion of this discussion in the Company’s Annual Report on Form 10-K referenced above.
ITEM 4. CONTROLS AND PROCEDURES
(a)
Disclosure Controls and Procedures
As of the end of the period covered by this report, the Company carried out an evaluation, under the supervision and with the participation of the Company’s management, including the Company’s principal executive officer and principal financial officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Exchange Act Rule 13a-15(e)). Based upon that evaluation, the principal executive officer and principal financial officer concluded that the Company’s disclosure controls and procedures were effective as of the end of the period covered by this report.
(b)
Changes in Internal Control Over Financial Reporting
During the Company’s fiscal quarter ended March 31, 2023, there have been no changes in the Company’s internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
On January 31, 2023, the Company completed the acquisition of ARB. The results of this acquisition are included in the Company's consolidated financial statements for the first three months of 2023. The total and net assets of ARB represented less than 1% of the Company's total assets and net assets as of March 31, 2023. The net sales of ARB represented less than 1% of the Company's consolidated net sales for the first three months of 2023
The scope of the Company's assessment of the effectiveness of internal control over financial reporting will not include the ARB acquisition noted above. This exclusion is in accordance with the SEC's general guidance that an assessment of a recently acquired business may be omitted from the Company's scope in the year of acquisition.
On November 4, 2022, the Company completed the acquisition of GGB. The results of this acquisition are included in the Company's consolidated financial statements for the first three months of 2023. The total and net assets of GGB represented 7% of the Company's total assets and 14% of the Company's net assets as of March 31, 2023. The net sales of GGB represented 4% of the Company's consolidated net sales for the first three months of 2023.
On May 31, 2022, the Company completed the acquisition of Spinea. The results of this acquisition are included in the Company's consolidated financial statements for the first three months of 2023. The total and net assets of Spinea represented 3% of the Company's total assets and 6% of the Company's net assets as of March 31, 2023. The net sales of Spinea represented less than 1% of the Company's consolidated net sales for the first three months of 2023.
The Company is currently integrating these acquisitions into its internal control framework and processes, and as prescribed by U.S Securities and Exchange Commission rules and regulations, the Company will include Spinea and GGB in the internal control over financial reporting assessment as of December 31, 2023.
42
PART II. OTHER INFORMATION
Item 1. Legal Proceedings
The Company is involved in various claims and legal actions arising in the ordinary course of business. U.S. Securities and Exchange Commission ("SEC") regulations require us to disclose certain information about environmental proceedings when a governmental authority is a party to the proceedings if we reasonably believe that such proceedings may result in monetary sanctions above a stated threshold. Pursuant to such regulations, the Company uses the maximum permitted threshold of $1 million or more for purposes of determining whether disclosure of any such proceedings is required. In the opinion of management, the ultimate disposition of these matters will not have a material adverse effect on the Company’s consolidated financial position or results of operations.
Item 1A. Risk Factors
The Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2022, included a detailed discussion of our risk factors. There have been no material changes to the risk factors included in the Company's Annual Report on Form 10-K for the year ended December 31, 2022. Investors should not interpret the disclosure of any risk factor to imply that the risk has not already materialized.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
Issuer Purchases of Common Shares
The following table provides information about purchases by the Company of its common shares during the quarter ended March 31, 2023.
| Period |
Total number
of shares
purchased
(1)
|
Average
price paid
per share
(2)
|
Total number
of shares purchased as part of publicly announced plans or programs |
Maximum
number of
shares that
may yet
be purchased
under the plans
or programs
(3)
|
||||||||||
| 1/1/2023 - 1/31/2023 | 202,205 | $ | 74.58 | 200,000 | 5,600,000 | |||||||||
| 2/1/2023 - 2/28/2023 | 340,256 | 84.77 | 190,000 | 5,410,000 | ||||||||||
| 3/1/2023 - 3/31/2023 | 291,102 | 81.54 | 281,010 | 5,128,990 | ||||||||||
| Total | 833,563 | $ | 81.17 | 671,010 | — | |||||||||
(1)
Of the shares purchased in
January, February and March, 2,205,
150,256
and 10,092, respectively, represent common shares of the Company that were owned and tendered by employees to
exercise stock options and to satisfy withholding obligations in connection with the exercise of stock options or vesting of restricted shares.
(2)
For shares tendered in connection with the vesting of restricted shares, the average price paid per share is an average calculated using the daily high and low of the Company's common shares as quoted on the New York Stock Exchange at the time of vesting. For shares tendered in connection with the exercise of stock options, the price paid is the real-time trading stock price at the time the options are exercised.
(3)
On February 12, 2021, the Company's Board of Directors approved a new share purchase plan, effective March 1, 2021, pursuant to which the Company may purchase up to ten million of its common shares, in the aggregate. This share purchase plan expires on February 28, 2026. Under this plan, the Company may purchase shares from time to time in open market purchases or privately negotiated transactions, and it may make all or part of the purchases pursuant to accelerated share repurchases or Rule 10b5-1 plans.
43
Item 6. Exhibits
| Certification of Richard G. Kyle, President and Chief Executive Officer (principal executive officer) of The Timken Company, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |||||
| Certification of Philip D. Fracassa, Executive Vice President and Chief Financial Officer (principal financial officer and principal accounting officer) of The Timken Company, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |||||
| Certifications of Richard G. Kyle, President and Chief Executive Officer (principal executive officer) and Philip D. Fracassa, Executive Vice President and Chief Financial Officer (principal financial officer and principal accounting officer) of The Timken Company, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |||||
|
Financial statements from the quarterly report on Form 10-Q of The Timken Company for the quarter ended March 31, 2023 filed on May 3, 2023, formatted in Inline XBRL: (i) the Consolidated Statements of Income, (ii) the Consolidated Statements of Comprehensive Income, (iii) the Consolidated Balance Sheets, (iv) the Consolidated Statements of Cash Flows and (v) the Notes to the Consolidated Financial Statements.
|
|||||
| Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | |||||
44
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| THE TIMKEN COMPANY | ||||||||
| Date: May 3, 2023 | By: /s/ Richard G. Kyle | |||||||
|
Richard G. Kyle
President and Chief Executive Officer (Principal Executive Officer) |
||||||||
| Date: May 3, 2023 | By: /s/ Philip D. Fracassa | |||||||
|
Philip D. Fracassa
Executive Vice President and Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) |
||||||||
45
TABLE OF CONTENTS
Part I. Financial InformationprintItem 1. Financial StatementsprintNote 1 - Basis Of PresentationprintNote 2 - Significant Accounting PoliciesprintNote 1 - Significant Accounting Policies"printNote 12 - Supply Chain FinancingprintNote 3 - Acquisitions and DivestituresprintNote 3 - Acquisitions and Divestitures (continued)printNote 4 - Segment InformationprintNote 5 - RevenueprintNote 5 - Revenue (continued)printNote 6 - Income TaxesprintNote 7 - Earnings Per ShareprintNote 8 - InventoriesprintNote 9 - Goodwill and Other Intangible AssetsprintNote 10 - Other Current LiabilitiesprintNote 11 - Financing ArrangementsprintNote 11 - Financing Arrangements (continued)printNote 13 - ContingenciesprintNote 14 - EquityprintNote 15 - Impairment and Restructuring ChargesprintNote 15 - Impairment and Restructuring Charges (continued)printNote 16 - Retirement Benefit PlansprintNote 17 - Other Postretirement Benefit PlansprintNote 18 - Accumulated Other Comprehensive Income (loss)printNote 19 - Fair ValueprintNote 19 - Fair Value (continued)printNote 20 - Derivative Instruments and Hedging ActivitiesprintNote 20 - Derivative Instruments and Hedging Activities (continued)printItem 2. Management's Discussion and Analysis Of Financial Condition and Results Of OperationsprintItem 3. Quantitative and Qualitative Disclosures About Market RiskprintItem 4. Controls and ProceduresprintPart II. Other InformationprintItem 1. Legal ProceedingsprintItem 1A. Risk FactorsprintItem 2. Unregistered Sales Of Equity Securities and Use Of ProceedsprintItem 6. Exhibitsprint